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ABSTRACT 
 
BIOTRANSFORMATION OF POLYMETHOXYFLAVONES BY GUT 
MICROBIOME AND MOLECULAR CHARACTERIZATON OF 
POLYMETHOXYFLAVONES BY SURFACE ENHANCED RAMAN 
SPECTROSCOPY 
September 2015 
CHANGCHU MA 
B.E., JIANGNAN UNIVERSITY, WUXI, CHINA 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST, MA 
Directed by: Professor Hang Xiao, Lili He 
 
Polymethoxyflavones (PMFs), a unique class of flavonoids found in citrus fruits has 
shown beneficial bioactivities. Biological fate of PMFs in the gastrointestinal tract is 
critical for their bioactivities. PMFs can be biotransformed to produce various 
metabolites with different bioactivities, and PMFs can also interact with the food matrix, 
which in turn affects their bioactivities. Therefore, we investigated the biotransformation 
of two PMFs, namely nobiletin (NBT) and 5-hydroxylnobiletin (5HN) by the gut 
microbiome. Mice were fed with NBT or 5HN, and small intestinal contents were 
collected and subjected to anaerobic fermentation by gut microbiome isolated from mice 
and human volunteers. HPLC analysis demonstrated that the gut microbiome largely 
deconjugated glucuronide and sulfate conjugates of NBT, 5HN and their metabolites and 
caused demethylation at certain positions of flavonoid. Moreover, the colonic microbial 
metabolites showed much stronger anti-carcinogenic effect than those found in the small 
intestine. The second part of this dissertation focuses on characterizing different PMFs, 
and their interaction with dietary protein by surface enhanced Raman spectroscopy 
 vii 
(SERS). 3-hydroxylnobiletin (3HN), 4-hydroxylnobiletin (4HN), and 5-
hydroxylnobiletin (5HN) exhibited significantly different SERS behaviors after binding 
with silver dendrites. 5HN had the highest peak intensity, while 3HN had the lowest peak 
intensity. The HPLC analysis revealed that 36.13 ±1.06% of 5HN, 18.40 ± 3.31% of 4HN 
and 9.66 ± 0.94% of 3HN were bound to silver dendrites. We speculated that different 
positions of hydroxylation of PMFs were critical for different binding affinities. 
Furthermore, the molecular interaction of NBT and 5, 3’, 4’- trihydroxylnobiletin (THN), 
and native and thermal denatured kappa casein, were characterized by SERS and 
fluorescence spectroscopy. Both SERS and fluorescence quenching studies showed that 
increased binding of NBT to thermal denatured casein than native casein. However, 
binding affinity of THN to thermal denatured casein decreased. Our results suggested that 
NBT interacted with kappa casein through hydrophobic interaction. THN interacted with 
kappa casein through hydrogen bonding and hydrophobic interaction, and hydrogen 
binding was the driving force. This dissertation demonstrates the significance of the 
microbial biotransformation of PMFs in the colon, and the feasibility of SERS to 
characterize PMFs and their interactions with protein.  
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CHAPTER 1 
INTRODUCTION 
 
Flavonoids have long been believed to display health-promoting effects on human health. 
Abundant in fruits and vegetables, more than 4000 flavonoid structures have been 
identified to date.
1
 So far, there are more than 20 polymethoxylated flavonoids being 
isolated and identified from different tissues of citrus plants, including hydroxylated 
polymethoxyflavones, polymethoxyflavones, polymethoxyflavanones, and 
polymethoxychalcone.
2
 Different varieties of citrus species contain different types and 
contents of polymethoxylated flavonoids. Almost exclusively found in citrus peels, 
polymethoxyflavones (PMFs), a unique class of flavonoid, has been of particular interest 
as they have been demonstrated to ameliorate human health problems by revealing a 
broad spectrum of biological activities including anti-inflammatory, anti-carcinogenic, 
anti-atherogenic, antioxidant, and antimicrobial properties.
3–16
  
 
The beneficial biological properties of dietary flavonoids are believed to correlate to its 
absorption, distribution, metabolism and excretion (ADME) in the human body. 
Therefore, biotransformation plays important roles in the biological activities of orally 
ingested bioactive compounds. Liver cytochrome P-450 (CYP) isozyme is the key 
enzyme observed to metabolize PMFs.
17,18
 The in vivo animal metabolism study of 
nobiletin, major PMF isolated from orange peels, reported that 3’-hydroxylnobiletin,  4’-
hydroxylnobiletin and 3’, 4’-dihydroxylnobiletin were major metabolites in their tissues 
and urine after mice or rats were orally administrated nobiletin.
19–22
 Recently, Zheng 
 2 
identified the mouse urine metabolites of 5-hydroxylnobiletin, as 5, 3’-
dihydroxylnobiletin, 5, 4’-dihydroxylnobiletin and 5, 3’, 4’-trihydroxylnobiletin.23 
Furthermore, stronger bioactivities, such as anti-inflammatory and anti- carcinogenic 
activity, of metabolites were revealed than their counterparts compounds.
22,23
 
 
However, most biotransformation studies of dietary flavonoids were focused on the phase 
I and phase II metabolism in the small intestine and liver. The colonic microbial 
metabolism of dietary flavonoids is insufficient and less studied. The gut microbes not 
only contribute to normal digestive function by fermenting unabsorbed nutrients in the 
upper gastrointestinal tract, but also metabolize xenobiotics, such as dietary flavonoids, 
drugs, with their respective enzymes. Furthermore, synthesis of B complex vitamins 
including thiamine, riboflavin, vitamin B12, and vitamin K is also correlated with the gut 
microbiome.
24
 Therefore, the gut microbiome has the ability to act as an organ with more 
biochemical conversion than, or at least equal to the liver.
25,26
 The major differences 
between hepatic and microbial metabolism is that the liver is primarily responsible for 
metabolism via oxidation and conjugation producing polar high molecular weight 
metabolites, while the gut microbiome is involved in reduction and deconjugation 
generating non-polar low molecular weight metabolites. Those microbial metabolites are 
often better absorbed than the counterpart compounds due to the mechanism of 
absorption and the large absorptive area available in the gut.
27
 Some microbial 
metabolites of isoflavones, equol, showed stronger bioactivities than isoflavones. So far, 
no group has studied and reported the biotransformation of PMFs by the gut microbiome. 
There is a significant gap in our understanding of the microbial metabolites of PMFs and 
 3 
how does the biotransformation by the gut microbiome affects biological activities of 
PMFs. 
 
The biological activities of PMFs isolated from citrus fruits particularly attract the 
attention, and also their numerous metabolites, characterization of different structure 
PMFs is important to further applications. Moreover, in the real world, those bioactive 
components coming from fruits and vegetables are consumed with food. Many potential 
health benefits and biological fate of flavonoids have been associated with their ability to 
interact and bind to macronutrients in foods, such as protein, carbohydrates and lipids. 
Among those interactions, flavonoid–protein interactions are a known phenomenon; 
those interactions not only play critical roles in food and beverage quality, but also the 
bioavailability and bioactivity of flavonoids.
28–35
 Particularly, whether the flavonoids-
protein interactions increase or decrease or have no effect on bioactivities and 
bioavailabilities of flavonoids is still debating. The mechanism behind is very 
complicated, which depends on the different structure of flavonoids and proteins, 
concentrations, pH, ionic strength and so on. Therefore, molecular characterization of 
interaction between PMFs and food macronutrients further help us understand how the 
interactions affect the bioactivities of PMFs  
 
Surface enhanced Raman spectroscopy (SERS) is a novel analytical method that 
combines Raman spectroscopy and nanotechnology. Raman spectroscopy is a vibrational 
spectroscopy providing rich characteristic information of molecular structure. It is caused 
by the interaction between energy change of inelastically scattered incident light and 
 4 
vibrational mode of chemical bonds within samples. However, only 1 in 10
6-8
 of photons 
undergoes Raman scattering, hence, the Raman scattering signal is relatively weak. 
Placing samples on or near the noble metal nanostructure, e.g. silver, gold or copper, can 
enhance the weak Raman scattering more than a million times through the amplification 
of electromagnetic fields. Raman spectroscopy and IR spectroscopy provide 
complementary information of chemical structure. Interference of water in Raman 
spectroscopy is smaller than IR spectroscopy, at the same time, the presence of metallic 
nanoparticles depress the fluorescence interference, and with its highly sensitive 
structural detection of trace amounts of analytes, SERS has been rapidly developed as a 
powerful tool for molecular detection and characterization, with applications in biology, 
medicine, materials science, biosensor and electrochemistry.
36–38
 SERS has been used to 
study ligand–protein interactions by dye-labeling methods and label-free methods. The 
specially designed Raman reporter labeled silver or gold nanoparticle is required for dye-
labeling methods, and the detection of Raman reporter signals indicates the interaction 
between ligand and protein.
39–41
 The label-free methods are based on the intrinsic Raman 
signals of ligand and protein. The changes in the Raman spectra of ligand protein 
incubation, either peak shifts or intensity, are a direct indication of ligand-protein 
interaction. The assignment of Raman peak also provides information of functional group 
involving in the interaction. 
 
Taken together, we have focused on two significant gaps that currently exist in the study 
of polymethoxyflavones, 1) the biotransformation of PMFs by the gut microbiome; 2) the 
interaction of PMFs with the food matrix. Surface enhanced Raman spectroscopy is 
 5 
introduced to molecularly characterize the PMFs and interactions between PMFs and 
protein. To achieve those goals, the following specific aims were pursued: 
Aim 1: Investigate the biotransformation of PMFs by the mouse and human gut 
microbiome. PMFs are anaerobically fermented by mouse and human gut 
microbes, and their metabolites will be determined using HPLC. A cell viability 
assay will be utilized to evaluate the inhibitory effects of microbial metabolites. 
We anticipate observing PMFs are biotransformed by gut microbiome, probably 
by deconjugation, and microbial metabolites exhibit stronger bioactivity than 
parent compounds. 
 
 Aim 2: Characterize monohydroxylated-PMFs by surface enhanced Raman 
spectroscopy. The position of the hydroxyl group in PMFs on the interaction with 
silver (Ag) dendrites (SERS substrate) and its relationship with the SERS 
enhancement and characterization is elucidated by SERS. HPLC is conducted to 
evaluate the binding percentage of monohydroxylated-PMFs to Ag dendrites. It is 
our expectation that SERS will enable us to characterize structure related PMFs, 
and the different monohydroxylated-PMFs will exhibit different SERS 
enhancement.  
 
 Aim 3: Characterize the molecular interaction between PMFs and kappa casein 
by surface enhanced Raman spectroscopy. The molecular interaction between 
different structure PMFs and different state of casein (native vs. thermal 
denatured) are characterized and quantified by SERS and fluorescence 
 6 
spectroscopy, respectively. We anticipate that both SERS and fluorescence studies 
will show consistent results that the interaction between PMFs and casein is 
influenced by their structure, and also propose a mechanism, such as possible 
bonding involved in the interaction.  
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Polymethoxyflavones 
2.1.1 Introduction to polymethoxyflavones 
Accumulated epidemiological evidence has consistently indicated that diets abundant in 
fruits and vegetables may have potential health-promoting effects, including anti-
inflammatory, antioxidant, antiallergic, antiestrogenic, antithrombotic, anticarcinogenic 
activities, cardiopretective and hepatoprotective effects, and this effect has been 
attributed to bioactive components present in these foods.
1,47,48
 Flavonoids are universally 
found in plants, and are recognized as the pigments responsible for the colors. They are 
also rich in seeds, citrus fruits, olive oil, tea, red wine, and coffee.  
 
According to the National Agricultural Statistics Service, there has been rapid growth of 
world citrus production during the last three decades. Production rose from 57.8 million 
tons in the 1980’s to 115.5 million tons in 2010-2011. China, Brazil and the United States 
are responsible for three countries produce about half of citrus production in the world. 
Orange production accounts for 70.7 million tons, then followed by tangerine (25.6 
million tons), lemon and limes (12.9 million tons), and grapefruit (6.4 million tons). 
Citrus fruits are processed, mainly to obtain juice, but also, they are used in the canning 
industry, and as a source of extract flavonoids and essential oils. During citrus fruits 
processing, approximately 50% of thick inedible leathery peels is yielded as 
byproducts.
49
 Orange peel has been widely used as a traditional medicine for relieving 
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stomach upset, skin inflammation, muscle pain, and ringworm infections in some 
countries.
3
 Its major constituents include flavonoids, mainly polymethoxylated 
flavonoids; terpenoids, such as limonene and linalool; and other volatile oils. Among 
these, polymethoxyflavones (PMFs) are a unique class of flavonoids, and almost 
exclusively exist in the citrus genus, particularly in the peels of sweet oranges (C. 
senensis) and mandarin oranges (C. reticulata).
2
  
 
2.1.2 Biological activities of polymethoxyflavones 
The reason citrus flavonoids, especially polymethoxyflavones (PMFs), have been 
received particular interest is many of these flavonoids posees a broad spectrum of 
biological activity, including anti-inflammatory, anti-carcinogenic, anti-atherogenic, 
antioxidant, and antimicrobial properties.
3–16
 Recent studies have revealed that some 
hydroxylated PMFs exerted more potent biological activities than those of their 
methoxylated counterparts, including anti-inflammation
22
 and anti-carcinogenesis.
50,51
 
 
Accumulating findings indicate that PMFs exhibit their anti-inflammatory activity by 
inhibiting enzymes involved in inflammation. PMFs have a wide range of suppressive 
activities toward free radical generation in enzymatic and cellular systems, and some of 
them may be important sources of effective free radical generation suppressors.
16
 
Nobiletin suppressed the interleukin (IL)-1-induced production of prostaglandin E2 
(PGE2) in human synovial cells, and selectively downregulated COX-2 mRNA 
expression. It also interfered with the lipopolysaccharide-induced production of PGE2 
and the gene expression of proinflammatory cytokines including IL-1α, IL-1β, TNF-α 
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and IL-6 in mouse J774A.1 macrophages. In addition, nobiletin downregulated the IL-1-
induced gene expression and production of proMMP-1/procollagenase-1 and proMMP-
3/prostromelysin-1 in human synovial fibroblasts.
16
 Guo also reported that nobiletin 
showed synergistic anti-inflammatory effects with sulforaphane studied in 
lipopolysaccharide-stimulated (LPS) RAW 264.7 cells. The combination of nobiletin and 
sulforaphane produced much stronger inhibitory effects on the production of nitric oxide, 
and decreased iNOS and COX-2 protein expression levels and induced heme oxygenase-
1 (HO-1) protein expression. It also suppressed LPS-induced upregulation of IL-1 mRNA 
levels and increased HO-1 mRNA levels.
52
 
 
Numerous in vitro and in vivo studies have shown protective effects of PMFs against 
carcinogenesis. Research showed that anti-carcinogenic activities of PMFs included anti-
proliferation, induction of cell cycle arrest, induction of cellular apoptosis, inhibited 
angiogenesis, inhibition of cell mobility, induction of cell differentiation, and inhibition 
of metastasis cascade. For example, nobiletin and tangeretin induced G1 cell cycle arrest 
in human breast and colon cancer cells.
53
 In human lung cancer H1299 cells, cell cycle 
analyses further revealed that hydroxylated PMFs caused significant increase in sub-
G0/G1 phase in the H1299 cells, and downregulated iNOS, COX-2, Mcl-1, and K-ras, as 
well as induced apoptosis evidenced by activation of caspase-3 and cleavage of PARP.
5
 
In an animal study, hydroxylated PMFs was administrated to azoxymethane treated mice, 
and the results showed that hydroxylated PMFs suppressed colonic aberrant crypt foci 
(ACF) and tumor formation through down-regulation of Wnt/β-catenin and epidermal 
growth factor receptor (EGFR) signaling pathways.
12
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Citrus flavonoids have been shown to help reduce cardiovascular disease symptoms as 
they were capable to influence and reduce hepatic production of cholesterol containing 
lipoproteins which resulted in the decreased levels of total cholesterol concentration in 
plasma.
54
 Whitman’s study indicated that nobiletin was able to diminish the circulating 
concentrations of very low-density lipoproteins (VLDLs) and low-density lipoproteins 
(LDLs) in the blood, and also could directly inhibit macrophage-derived foam-cell 
formation at the site of the lesion within a vessel wall by modulating macrophage 
metabolism of the specific class A scavenger receptor (SR-A) ligand, and acetylated 
LDL.
55
 
 
Nobiletin, 5- hydroxylnobiletin and tangeretin exhibited antimicrobial activities against 
Bacillus cereus, Bacillus coagulans, Bacillus subtilis, Staphylococcus aureus, 
Escherichia coli and Pseudomonas aeruginosa. Moreover, their antimicrobial activities 
to Gram-positive stains was stronger than Gram-negative.
7
 In vitro antibacterial and 
antifungal activities of several polymethoxychalcones was reported by Rostom, including 
activity against S. aureus and B. subtilis as Gram-positive bacteria; E. coli and P. 
aeruginosa as Gram-negative bacteria. The antimicrobial activity was correlated to 
structural variations and modifications of those polymethoxychalcones. One 
polymethoxychalcone they synthesized was four times superior to ampicillin against P. 
aeruginosa.
8
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2.1.3 Chemistry, isolation and identification of polymethoxyflavones 
Over 4000 structurally unique flavonoids have been identified in plants.
1
 Flavonoids are 
low molecular weight compounds, consisting of phenylbenzo-pyrones 
(phenylchromones) with an assortment of structures arranged in a C6–C3–C6 
configuration. Essentially, the structure consists of two benzene rings, A and B, linked 
through a heterocyclic pyran or pyrone ring, C, in the middle. The benzene ring A is 
derived from the acetate/malonate pathway, while ring B is derived from phenylalanine 
via the shikimate pathway.
57
 Flavonoids are usually subdivided into 12 subclasses, e.g. 
flavonols, flavones, flavanones, flavanols (or catechins), isoflavones, flavanonols, 
chalcone, and anthocyanidins.  
 
Polymethoxyflavones are a unique class of dietary flavonoids bearing two or more 
methoxyl groups on their basic heterocyclic C6–C3–C6 skeleton with a carbonyl group at 
position 4. So far, more than 20 polymethoxylated flavonoids have been isolated and 
identified from different tissues of citrus plants, including hydroxylated PMFs, PMFs, 
polymethoxyflavanones, and polymethoxychalcone. (Figure 2.1)
2
 The types and contents 
of PMFs vary among different varieties of citrus species.  
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Figure 2.1 Hydroxylated PMFs, PMFs, polymethoxyflavanones, and 
polymethoxychalcones isolated from sweet orange peel.2 
 
Owing to the particularly interesting biological activities of PMFs, separation, 
identification and characterization of PMFs have been studied. PMFs are mainly isolated 
and separated from citrus fruit peels,
58–65
 oil,
66–69
 juice,
70
  leaves,
63,71
 and mouse urine 
after administrated PMFs
20,21,23,72
 by thin-layer chromatography (TLC),
58
 capillary 
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electrochromatography (CEC),
66
 flash column chromatograph,
2,62,65,73
 supercritical fluid 
chromatography (SFC),
21,60,67,72
 gas chromatography (GC),
68
 and high pressure liquid 
chromatograph (HPLC).
2,20,23,59,61–64,69–71,74–76
 HPLC is the most commonly used 
separation method for PMFs. Some research groups reported the use of reversed phase 
column for separation.
2,23,61,63,64,74–76
 The detectors used including photodiode array 
detectors,
20,62,64,69
refractive index detectors,
71
 with UV-detectors
2,21,59,61,63,74,75
 being the 
most commonly used. Recently, an electrochemical detector was also reported to detect 
5-hydroxy polymethoxyflavones, and it exhibited over 160 times higher sensitivity in 
comparison with a previously reported method using UV detection.
23,76
 Mass 
spectrometry (MS) and nuclear magnetic resonance (NMR) are widely used after 
separation by chromatography for identification of PMFs.
2,21,23,61,62,65,68,69,71,73,77
 
 
2.1.4 Metabolism of polymethoxyflavones 
The beneficial biological properties of dietary flavonoids are believed to correlate to their 
absorption, distribution, metabolism and excretion (ADME) in the human body. Even 
though the ADME of dietary flavonoids is not well understood, considerable information 
is available regarding the metabolism of dietary flavonoids in animals and to a very 
limited extent in humans. Generally speaking, the dietary flavonoids may exist in the 
food as flavonoids glycosides, polymers. Therefore, the first step upon ingestion is 
release of dietary flavonoids from their food matrix by deglycosylating and cleaving 
those compounds to aglycones. This step is prerequisite for absorption through the 
intestinal barrier. Aglycones, monomers to trimers of flavonoids can rapidly be absorbed 
by enterocytes through passive diffusion. During intestinal absorption and passage in the 
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liver, dietary flavonoids undergo phase I and phase II metabolism. Phase I metabolism 
mainly involves oxidation, reduction, and hydroxylation. It introduces reactive and polar 
group into their substrates, e.g. hydroxylation catalyzed by the cytochrome P-450 (CYP). 
Phase II metabolism mainly involves sulphation which is catalyzed by sulfotransferases 
(SULT), glucuronidation which is catalyzed by uridine-5′-diphosphate 
glucuronosyltransferases (UGT), and methylation which catalyzed by catechol-O-methyl 
transferase (COMT). Partial aglycones, phase I and phase II metabolites enter into 
systemic circulation, tissue disposition, and excreted by urine. The dietary flavonoids that 
are unabsorbed in the small intestine, as well as those compounds absorbed and 
metabolized in the liver, and excreted with bile enter into the colon. The gut microbiome 
hydrolyze the unabsorbed glycosides and cleave the conjugates (glucuronides and 
sulfates) to aglycone, then break larger aglycones to simpler molecules in the colon. The 
microbial metabolites are either excreted by feces, or re-excreted via bile and can 
undergo enterohepatic circulation. Kemperman summarized ADME of dietary 
flavonoids, and illustrated the metabolic fate of dietary flavonoids in the Figure 2.2.  
 15 
 
Figure 2.2 Metabolic fate of dietary flavonoids. Partial absorption of flavonoids occurs in 
the small intestine, with modification by phase I and phase II enzymes, excretion with 
bile back into the small intestine, deconjugation by microbial enzymes and microbial 
conversion of the flavonoids in the colon, absorption of microbial metabolites or fecal 
excretion, deconjugation and excretion via bile or urine.78 
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Compared to other dietary flavonoids, the metabolism of PMFs is less studied. However, 
there is evidence that PMFs undergo biotransformation in vivo and produce metabolites 
with different bioactivities and pharmacological properties. Therefore, the metabolism 
and identification of metabolites of PMFs are of special interest. Like other dietary 
flavonoids, the interaction between PMFs and liver cytochrome P-450 (CYP) isozymes 
has been observed. CYP is the key enzyme system involved in metabolism of PMFs, and 
is capable of catalyzing hydroxylation and demethylation reactions.  
 
In an in vitro experiment, when tangeretin was incubated with Aroclor-induced rat liver 
microsomes, the major metabolites were identified as 4’-dihydroxytangeretin, 3’, 4’-
dihydroxylnobiletin and 5, 4’-dihydroxytangeretin.17 However, in another in vitro 
metabolism study with human CYP, four of five metabolites were demethylated at 
position 4’, and the major metabolite was 4’-demethyltangeretin. Interestingly, 5, 6-
dihydroxylnobiletin was found to be a second abundant metabolite.
18
 In the in vivo 
biotransformation study of tangeretin by repeatedly gavage feeding on rats, 10 
metabolites were identified. Among 10 identified metabolites, 7 metabolites were 
demethylated at position 4’ including the major metabolites, 4’-demethyltangeretin and 
3’, 4’-dihydroxylnobiletin. Position 6 was found to be the second most frequent site for 
demethylation.
79
 Hence, it can be concluded that position 4’ of tangeretin is the primary 
site, and position 6 is a second primary site for demethylation by COMT. Also, urine 
analysis determined that 38% of the tangeretin metabolites were excreted as conjugates. 
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In vitro nobiletin metabolism using rats, pigs and hamster liver microsomes with 12 
recombinant rat CYPs, demonstrated that nobiletin was metabolized to 4′- 
hydroxylnobiletin, 7- hydroxylnobiletin, 6- hydroxylnobiletin, 3′,4′-di hydroxylnobiletin 
and 6,7-di hydroxylnobiletin. CYP2C11, CYP2D1, CYP3A1, CYP3A2 and CYP2C12 
are responsible for the demethylation at position 6, 7, 3’ and 4’; while CYP1A1 and 
CYP1A2 preferentially catalyzed demethylation at position 3’and 4’.80 Four years later, 
the same group reported in vitro metabolism of nobiletin by human liver microsomes and 
cytochrome P450. Human liver microsomes containing CYP enzymes catalyzed nobiletin 
to 4′- hydroxylnobiletin, 7- hydroxylnobiletin, and 6- hydroxylnobiletin with a relative 
ratio of 1:4.1:0.5, respectively. 7- hydroxylnobiletin is the major metabolite by human 
liver microsomes. Human CYP1A1, CYP1A2 and CYP1B1 showed the highest activity 
for demethylation of nobiletin at the position 4’, whereas human CYP3A4 and CYP3A5 
were the key enzymes involved in the demethylation of nobiletin at 7- and 6-positions.
81
 
In vitro absorption of nobiletin using Caco-2 cell as model showed that nobiletin 
preferentially accumulated in a differentiated Caco-2 cell monolayer. In vitro metabolism 
study of nobiletin by treating nobiletin with rat liver S-9 mixture showed that after 24 
hours treatment, only 7.0% of nobiletin was metabolized to metabolites, and 3’- 
hydroxylnobiletin was the major metabolite.
82
 
 
An in vivo animal metabolism study of nobiletin was conducted by Murakami,
19
 
Yasuda,
20
 and Li.
21,22
 Nobiletin was orally administrated to mice or rats, their tissue and 
urine were collected. Murakami investigated the tissue distribution of nobiletin, and 
found that nobiletin accumulated in a wide range of organs including the stomach, small 
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and large intestines, liver, and kidney during a 1-to 4-hour period after a single dose. The 
observed localization of nobiletin in mucous membranes has been due to its high 
molecular hydrophobicity. Moreover, 3’- hydroxylnobiletin was detected as a major 
metabolite in serum and urine. Subsequently, both Yasuda and Li reported that 4’-
hydroxylnobiletin was a major metabolite, while Li also reported 3’-hydroxylnobiletin, 
and 3’, 4’-dihydroxylnobiletin were minor metabolite. Recently, Zheng identified the 
mouse urine metabolites of 5- hydroxylnobiletin as 5, 3’-di hydroxylnobiletin, 5, 4’-
dihydroxylnobiletin and 5, 3’, 4’-trihydroxylnobiletin. Similarly, 5, 4’-
dihydroxylnobiletin was a major urinary metabolite.
23
 Thus, animal studies have shown 
the methyl groups on the B ring of nobiletin and 5- hydroxylnobiletin, and particularly 
4’-methyl group, are easily removed by methyl transferase enzymes in mice or rats. 
When Li and Zheng treated mice urine samples with β-D-glucuronidase and sulfatase, 
increased level of those metabolites were suggesting that the free hydroxyl groups after 
demethylation could be deconjugated by deconjugation enzymes such as glucuronidases 
or sulfates. 
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2.2 Gut microbiome 
2.2.1 Introduction to the gut microbiome 
The gastrointestinal tract is populated with 100 trillion (10
14
) microbes which makes the 
human gastrointestinal tract one of the most populated microhabitats on earth.
83
 It has 
been generally accepted that it contains 500 to 1,000 species.
84
 In terms of genetic 
diversity, the gut microbiome surpasses the human genome by 100 fold. The gut 
microbiome composition of each individual is unique and develops under key influences 
of genotype, physiological status of the host, diet, and environment.
85–88
 The human 
gastrointestinal tract (GIT) is sterile at birth, and colonization of the GIT of neonates 
starts shortly after birth. Most of this inoculum is derived largely from the mother’s 
vaginal and fecal microbiome if delivered by conventional birth or from environment if 
delivered by caesarean delivery. Interestingly, the composition of the GIT microbiome of 
a 1 years old child is essentially the same as that of an adult.
89
 The GIT includes mouth, 
pharynx, esophagus, stomach, small intestine and large intestine. The cecum, appendix, 
colon, rectum and anal canal comprise the large intestine. Moving along these different 
sections of the GIT, like a pyramid, there is a progressive increase in both numbers and 
species towards the ileocecal junction to the large intestine. Up to 10
11
 – 1012 CFU/g is 
estimated in the large intestine. Figure 2.3 summarized spatial and temporal aspects of 
GIT microbiome composition.
84 
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Figure 2.3 Spatial and temporal aspects of GI tract microbiome composition. A: 
variations in microbial numbers and composition across the length of the gastrointestinal 
tract. B: longitudinal variations in microbial composition in the intestine. C: temporal 
aspects of microbiome establishment and maintenance and factors influencing microbial 
composition. 84 
 
The gut microbiome contribute to normal digestive function, and ferment unabsorbed 
nutrients, such as carbohydrates and proteins in the upper GIT. Moreover, these microbes 
and their respective enzymes are able to metabolize xenobiotics, such as dietary 
flavonoids, drugs, far more extensively than any other part of the body. The gut 
microbiome also play an important role in synthesis of B complex vitamins including 
thiamine, riboflavin and vitamin B12, and vitamin K.
24
 Therefore, the gut microbiome 
has the ability to act as an organ with more biochemical conversion than, or at least equal 
to the liver.
25,26
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Members of the human gut microbiome are key players in maintaining human health and 
well-being. They are implicated in developmental, immunological, and nutritional host 
functions and have thus a profound impact on human health far beyond the fermentation 
of non-digestible food compounds. In turn, distortions in gut microbial community 
structure and/or functionality are thought to cause several intestinal diseases. 
26
 
 
2.2.2 Dietary flavonoids - gut microbiome interaction 
2.2.2.1 Microbial metabolism of dietary flavonoids 
The diverse gut microbiome plays a critical role in the metabolism of dietary flavonoids. 
The overall metabolism of dietary flavonoids is discussed in the section 2.1.4. Most 
human intervention studies on the ADME of dietary flavonoids focused on the phase I 
and phase II metabolism in the small intestine and liver. However, the microbial 
metabolism of dietary flavonoids is insufficient. The major differences between hepatic 
and microbial metabolism is that the liver is primarily responsible for metabolism via 
oxidation and conjugation producing polar high molecular weight metabolites, while the 
gut microbiome is involved in reduction and deconjugation generating non-polar low 
molecular weight metabolites. Those microbial metabolites are often better absorbed than 
the parent compounds due to the mechanism of absorption and the large absorptive area 
available in the colon.
27
 
 
In general, the gut microbes generate O- and C-deglycosidases and hydrolases to cleave 
the unabsorbed glycosides and polymers from the small intestine. The release of aglycone 
and oligomers enhances their absorption. Secondly, microbial enzymes, such as 
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glucuronidase and sulphatase, deconjugate the phase II metabolites. After deconjugation, 
there are two possible routes available, one is reuptake of the intact dietary flavonoids 
through the colonocytes and passage into the bloodstream (as free or conjugated forms) 
and liver. The other route is breakdown of the dietary flavonoids structure into smaller 
metabolites. The aglycones may be degraded by gut microbiome to produce simpler 
phenolic compounds by backbone rupture producing phloroglucinol (derived from A 
ring), and hydroxylated forms of phenylacetate or phenylpropionate are obtained, derived 
from the B ring. For example, quercetin gives 2-(3,4-dihydroxyphenyl)acetic acid, 2-(3-
hydroxyphenyl)acetic acid, and 3,4-dihydroxybenzoic acid from the B ring, whereas 
phloroglucinol, 3-(3,4-dihydroxyphenyl)propionic acid, and 3-(3-
hydroxyphenyl)propionic acid are produced from the A ring. Naringenin gives 3-(4-
hydroxyphenyl)propionic acid and phlorogucinol.
90
 Dehydroxylation, demethoxylation 
and demethylation, and isomerization of both intermediates and end products can occur at 
various points in the pathway.
91
 So far, only a limited number of bacterial species have 
been identified as being involved in the metabolism of dietary flavonoids. Table 2.1 
summarizes an overview of the metabolites produced from known flavonoids by gut 
microbiome strains.
48
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Table 2.1 The gut microbiome involved in the metabolism of certain flavonoids. 48 
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Microbial metabolism therefore not only is a prerequisite for absorption but also 
modulates the biological activity of dietary flavonoids, leading to the release of more 
active metabolite in the body. Monagas summarized the microbial metabolites of 
flavanols , hydroxyphenyl-γ-valerolactones, and several phenolic acids in term of their 
antioxidant, anti-proliferative and anti-inflammatory, and anti-thrombitic effects, as well 
as their modulation of the gut microbiome.
92
 The 3,4-dihydroxyphenylacetic and 4-
hydroxyphenylacetic acid metabolites have been reported to exert higher inhibition of 
platelet aggregation than their precursors rutin or quercetin.
93
 In addition, the 
hydroxyphenylacetic and phenylpropionic derivatives, produced by microbial 
degradation of many flavonoids, have structural characteristics similar to apocyinin, a 
relevant inhibitor of NADPH oxidase. This enzyme is associated with the endothelial 
function, and these metabolites could act as inhibitors of this enzyme.
91
 
 
The microbial biotransformation of isoflavones has attracted particular attention for the 
higher antioxidant activity of the microbial metabolites, equol, than its parent compound, 
daidzein. Isoflavones, a class of nonsteroidal estrogens that are similar in chemical 
structure to estrogens, are abundant in soy. Almost all soy isoflavones exist as glucosides, 
and require the conversion of glucosides into the principal bioactive aglycones (daidzein, 
genistein, and glycitein) by β-glucosidase for absorption. The aglycones are either 
absorbed intact or further metabolized by gut microbiome. Genistein is metabolized to p-
ethylphenol and 4-hydroxyphenyl-2-propionic acid, whereas daidzein is reduced to O-
demethylangolensin (O-DMA) and equol.
94
 Interestingly, humans produce relatively low 
levels of equol, in contrast to animal species assayed such as mouse, rat, and monkey.
94,95
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Furthermore, not all individuals consuming daidzein produce equol and O-DMA.
96
 For 
example, only about 35% of subjects excreted substantial amounts of equol after 
consuming soy.
97
 The inability of some subjects to produce equol is a consequence of the 
lack of specific microbes of the gut microbiome.
95
 In addition to O-DMA and equol, 
dihydrodaidzein, tetrahydrodaidzein, 3’-hydroxydaidzein, 6-hydroxydaidzein, 8-
hydroxydaidzein, 3-(4-hydroxyphenyl)benzopyran-4,7-diol, and 2-dehydro-O-DMA have 
also been reported to be microbial metabolites of daidzein.
94
 Therefore, these isoflavones 
are transformed by deglucosylation, reduction, C-ring cleavage, and hydroxylation 
reactions in the gut. 
 
Compared to other subclasses of flavonoids, such as isoflavones and flavonols, the 
microbial biotransformation of flavones is less studied. The microbial metabolism of 
homoorien that is C-glycosylflavone by human fecal suspension was investigated. 
Homoorientin was catalyzed to 6-C-glucosyleriodictyol.The C-glycosyl bond was then 
cleaved to produce eriodictyol, which was subsequently converted to 3,4-
dihydroxyphenylpropionic acid and phloroglucinol via ring fission. On the other hand, 
luteolin, the aglycone of homoorientin, was produced in relatively low yields via direct 
cleavage of the C-glycosyl bond.
98
 Although those flavones possessing similar carbon 
skeletons, different position of ring fission or resistant to ring fission were found. The pig 
cecum microbiome metabolized hispidulin (5, 7, 4’-trihydroxy-6-methoxyflavone) to 
scutellarein (5,6,7,4’-tetrahydroxyflavone), and 3-(4-hydroxyphenyl)-propionic acid; 
apigenin (5, 7, 4’-trihydroxyflavone) to 3-(4-hydroxyphenyl)-propionic acid and 3-
phenylpropionic acid, and luteolin (5 ,7, 3’, 4’-tetrahydroxyflavone) to 3-(3-
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hydroxyphenyl)-propionic acid, respectively. Hispidulin was rapidly underwent O-
demethylation to scutellarein in 10 hours, and the demethylation occurred at the position 
6. Breakdown of the heterocyclic ring of scutellarein, apigenin and luteolin occurred at 
the position between 4 and 5. Notably, no degradation of chrysin (5, 7 –
dihydroxyflavone) was observed.
99
 Griffiths incubated apigenin, apiin (apigenin 7-
apiosylglucoside), chrysin and tectochrysin with microbiome derived from rat intestine, 
and also found 3-(4-hydroxyphenyl)-propionic acid after apigenin, apiin incubation 
sample, and no metabolites were found in chrysin and tectochrysin incubation sample.
100
 
Both Griffins and Labib concluded that 5-, 7- and 4’-hydroxy groups in the molecule are 
necessary for the microbial breakdown of flavones.  
 
2.2.2.2 Modulation of the gut microbiome by dietary flavonoids 
Dietary flavonoids are metabolized by gut microbiome, on the other hand, those 
unabsorbed dietary flavonoids and their microbial metabolites, in addition to their direct 
beneficial effect on the human tissues, exert significant effects on the gut environment by 
modulation of the microbiome. However, there are remarkably few studies investigating 
the effect of polyphenols on the composition and activity of the gut microbial 
community. There is a significant gap in our understanding of the dietary flavonoids – 
gut microbiome interactions. Nevertheless, there is evidence from in vitro, animal and 
human studies that certain doses of selected dietary flavonoids influence gut microbial 
populations, including inhibition if certain bacterial groups.  
For example, tea polyphenols, including epicatechin, catechin, 3-O-methylgallic acid, 
gallic acid, and caffeic acid, which have been identified as responsible for the inhibition 
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of growth on certain pathogenic bacteria, such as Clostridiumperfringens, 
Clostridiumdifficile, and Bacteroides spp. growth, whereas commensal anaerobes such as 
Clostridium spp., Bifidobacterium spp., and probiotic microbes such as Lactobacillus 
spp. were less severely affected.
101
 Similar results were obtained in another in vitro study 
of (-)-epicatechin and (+)-catechin using a batch-culture fermentation system with human 
feces. (+)-Catechin significantly inhibited growth of Clostridium histolyticum, whereas 
growth of members of the Clostridium coccoides–Eubacterium rectale group and 
Escherichia coli was significantly enhanced and growth of Bifidobacterium and 
Lactobacillus spp. remained relatively unaffected.
102
 Those results indicated that tea 
polyphenol exerted significant effects on the gut environment by modulation of the gut 
bacterial population, probably by acting as metabolic prebiotics. The animal study 
showed that rats treated with red wine polyphenols had significantly lower levels of 
Clostridium spp. and higher levels of Lactobacillus spp..
103
 Moreover, a human 
intervention study with 10 male volunteers who received red wine for 20 days showed 
consumption of red wine polyphenol for 4 weeks significantly increased the number of 
Enterococcus, Prevotella, Bacteroides, Bi-fidobacterium, Bacteroides uniformis, 
Eggerthella lenta, and Blautia coccoides–Eubacterium rectale groups.104 
 
2.2.3 Models to study dietary flavonoids - gut microbiome interaction 
It is a particularly challenging task to study dietary flavonoids - gut microbiome 
interactions and their relevance to human health. The high diversity of dietary flavonoids, 
their bioavailability and the myriad molecular mechanisms by which they may trigger 
health responses, the large inter-individual variability in both composition and activity of 
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gut microbiome, all contribute to the complexity. The inaccessibility of the human gut 
prevents the direct examination of the metabolic and ecological activity of the 
microbiome, as well as raising ethical issue. Controlling and evaluating all, often 
interrelated, variables within one experimental setting are not feasible. Consequently, to 
get the whole picture, a multidisciplinary approach, combining both in vitro and in vivo 
animal and human studies, is the key to success. 
 
Currently available in vitro gut models range from static batch incubations, semi-
continuous culture systems, to multistage continuous culture systems. A more intricate 
system aiming to study the ecological system present in the GIT was developed, 
consisting of a five-stage reactor named simulated human gut microbial ecosystem 
(SHIME).
105
 A defined bacterial strain, ileostomy fluid or microbes from freshly voided 
human or animal feces, animal large intestine cultured in a suitable medium to which   
defined dietary flavonoids was added, and monitoring the disappearance of dietary 
flavonoids, formation of metabolites or changes in the microbiome.
27
 Considering the 
inaccessibility of the human gut does not permit the use of human gut contents for in 
vitro experiments, it is believed that such an environment is more closely simulated with 
the use of human feces than with the use of gut contents from other animals. Thus, in 
vitro studies carry great value to study a specific class of dietary flavonoids, its 
metabolism and differentiation with fully controlled variables. The biggest challenge with 
in vitro simulation of the gut environment is the creation of a fermentation system 
containing microbial numbers and diversity similar to the human gut.  
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For in vivo studies, the use of animal models has some economical and logistical 
advantages over the use of human models: easier experimental set up and less stringent 
ethics regulations apply. The simplest approach to elucidate microbial metabolism could 
be compared bile metabolites with fecal metabolites by collecting animal urine and feces. 
Another methodology for locating the production of specific metabolites includes the 
removal of the stomach, small intestines, caecum and colon of rats. Furthermore, 
inoculation of germ-free rodents with a human fecal microbiome, human- microbiome 
associated (HMA) animals, effectively mimics human microbial metabolism and thus 
provides a reliable model to study the human gut microbial ecosystem as well as 
metabolism.
96,103
 The use of animals has allowed the effects of the animal microbiome 
and human-type microbiome to be compared. However, there is evidence of variability 
between animal species and man.
106
 This inter-species variability has led scientists to use 
human volunteers instead of animals to determine dietary flavonoids - gut microbiome 
interaction in the human intestine. Human in vivo studies use volunteers, either free-
living or following prescribed diets, and to collect their feces and urine for analysis. 
Healthy volunteers can be compared with volunteers who have undergone an ileostomy 
but who are otherwise enabling metabolism in the small intestine to be distinguished 
from that in the large intestine.
27,106
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2.3 Surface enhanced Raman spectroscopy 
2.3.1 Introduction to Surface enhanced Raman spectroscopy 
Raman spectroscopy is a branch of vibrational spectroscopy; both the intensity and 
frequency of induced molecular vibrations are sensitive to the chemistry and environment 
around the individual atoms. The Raman scattering was first experimentally observed and 
reported by Raman and Krishnan in 1928.
107
 When monochromatic radiation of 
frequency (v0) is incident on a sample, it generates Rayleigh scattering and Raman 
scattering. Rayleigh scatting is a elastically scattered radiation that radiation with the 
same frequency as the incident radiation. While Raman scattering is inelastic scattering, 
thus, the change in frequencies observed when a photon undergoes Raman scattering is 
attributed to the excitation (or relaxation) of vibrational modes of a molecule. Since 
different functional groups have different characteristic vibrational energies, every 
molecule has a fingerprint Raman spectrum. Raman and infrared (IR) spectroscopy are 
complementary techniques. Various stretching and bending deformation modes of 
individual chemical bonds result in the discrete vibrational transitions occurring in the 
ground electronic state of molecules. In infrared (IR) spectroscopy, the absorption of 
incident electromagnetic radiation at a particular frequency (vi) in the IR region is related 
to a specific vibrational excitation energy. In contrast, in Raman spectroscopy, the 
exciting or incident light beam is at a frequency (v0) that may correspond to the visible, 
UV or near-infrared region of the electromagnetic spectrum. The inelastic scattering of 
the incident radiation, which results in a Raman shift (Δv = vi), is related to the energy of 
a vibrational transition within a sample molecule. Stokes’ transitions are those in which 
the molecule is excited by the radiation, whereas anti-Stokes’ transitions are those in 
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which the molecule is de-excited (Figure 2.4). The intrinsic dipole moment with 
molecular vibration is changed in order to IR absorption, whereas Raman scattering 
depends on changes in the polarizability of functional groups as the atoms vibrate. 
Therefore, polar groups such as C=O, N-H and O-H have strong IR bands, while 
nonpolar groups such as C=C, C-C and S-S have intense Raman bands. One advantage of 
Raman spectroscopy is that it produces less water interference. As a consequence, Raman 
spectroscopy is usually more suitable for the in vivo or in situ study of biological systems, 
including foods, which are primarily aqueous in nature. However, because Raman 
scattering is inherently weak, giving signal intensities in the order of 10
-9 
to 10
-6
 of those 
of Rayleigh scattering, fairly high concentrations of the target analytes are required in 
samples. Another drawback of Raman spectroscopy is the interference from fluorescence 
in some samples, which may completely obscure the Raman scattering signals. 
 
Figure 2.4 The relationship between infrared, Rayleigh scattering and Raman scattering. 
108
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Because of the inherently small intensity of the Raman signal, the sensitivity limits the 
applicability of Raman scattering for many years. In 1977, Jeanmaire and Van Duyne 
demonstrated that the magnitude of the Raman scattering signal can be greatly enhanced 
when the sample is placed on or near a roughened nanoscale metallic substrate, such as 
silver, gold, or copper.
109
 Therefore, surface enhanced Raman spectroscopy (SERS) is 
combination of Raman spectroscopy and nanotenology. The illustration of SERS 
enhancement showed in the Figure 2.5.  
 
Figure 2.5 Illustration of SERS enhancement.36 
 
There are two proposed mechanisms of SERS enhancement, chemical enhancement and 
electromagnetic enhancement. Chemical enhancement primarily involves charge transfer 
mechanisms, and a charge-transfer state is created between the metal and molecules.
110
 
This mechanism is site-specific and analyte-dependent. The molecule must be directly 
adsorbed to the roughened surface to experience the chemical enhancement.
111
 Presently, 
the experimentally obtained chemical mechanism contributes enhancement factors of 
only 5 – 10 times.37 The other mechanism involved in signal enhancement is 
electromagnetic enhancement. Strong electromagnetic fields are generated when the 
localized surface plasmon resonance (LSPR) of nanoscale roughness metallic substrate is 
excited by visible light. When the sample is placed to these intensified electromagnetic 
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fields, the magnitude of the induced dipole increases, and accordingly, the intensity of the 
inelastic scattering increases.
112
 The size, shape, aggregation and material of the 
nanoscale roughness features must be considered in term of electromagnetic 
enhancement, because the light concentration occurs preferentially in the gaps, crevices, 
or sharp features of metals. The average for the SERS enhancement is around 10
6
, but the 
electromagnetic enhancement for SERS is theoretically calculated to reach factors of 10
10 
– 1011.113 
 
2.3.2 SERS substrates 
The noble metal substrate is the key player in the in the enhanced scattering process. 
Therefore, the choice and/or fabrication of the noble-metal SERS substrates in most 
critical aspect of performing a SERS experiment. SERS substrates require chemical and 
biological compatibility with the samples that have to be measured, chemical and 
temporal stability, reliability and reproducible, and economical preparation. 
 
Typically, there are 3 SERS substrate categories: (1) Nanoparticles in suspension; (2) 
Nanoparticles immobilized on solid substrates; (3) Nanostructures fabricated directly on 
solid substrates.
114
 The commonly used SERS substrates are metal colloids and 
nanoparticles in diameters between 10 and 200 nm in suspension. The colloids dispersion 
of metal nanoparticles are prepared by reduction of the respective metal salts with various 
reduction agents. The fabrication of metal colloids and nanoparticles only require simple 
chemical laboratory equipment. However, particles in colloidal dispersions often show a 
size and shape distribution, leading to an undesired broadening of the resonance. Another 
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drawback for using colloids is their poor reproducibility, and the nanoparticles tend to be 
randomly aggregated during drying which results in extremely inconstant signals from 
spot to spot. Immobilizing the nanoparticles on planar platforms is another approach to 
fabricate a SERS substrate. Modification of the glass surface by derivatized silanes, such 
as aminopropyltrimethoxisilane (APTMS), could irreversible immobilize gold or silver 
particles on glass supports.
115
 However, the adhesion of nanoparticles to the solid 
supports is usually very poor. Electrochemically roughened metal electrodes were the 
first substrates showing surface-enhanced Raman scattering.
116
 Rough surfaces and island 
films are prepared by deposition onto inexpensive rough substrates. For example, gold 
dendrite nanostructures were prepared by using a galvanic exchange reaction achieving 
distances in the range of the effective plasmon resonance.
117
 Rough surfaces may offer 
high sensitivity because their larger surface area may provide more target molecules. The 
SERS substrates could be also prepared by templates to achieve a highly reproducible 
and large-scale production using photolithography and nanolithography. Different 
fabrication strategies based on the coating of template structures or, on the other hand, the 
additional removal of the template. Nanosphere lithography (NSL) is the most prominent 
example for removal of the template structure for some SERS array fabrication 
approaches. A solvent containing same size of nanospheres is arranged to dry in a dense 
monolayer on a substrate serving as a mask for a directed deposition of a metal layer, 
giving an hexagonal array of triangles.
118
 Photolithography and nanolithography allow 
the fine control over the size and shape of the nanostructures so that achieve very high 
reproducibility in the SERS intensities. 
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Silver dendrites, an easy, convenient, and cost-effective way for SERS analysis was 
designed by He’s group.119  Silver dendrites are prepared via a simple replacement 
reaction:  Zn + AgNO3          Ag +ZnNO3. Basically,  a zinc plate is pre-cleaned to 
remove surface contaminants,  then immersed into the AgNO3 solution. The different 
morphologies of silver nanostructures are obtained by controlling silver ion concentration 
and reaction time. Lastly, the formed silver nanostructures are carefully peeled off the 
zinc plate, rinse several times to remove excessive chemical residues, and stored in the 
vial containing water. The desired silver dendrites are obtained by immersing zinc plate 
into 200 mmol/l AgNO3 solution for 1 minute. Under SEM, the nanostructure is 
composed of ∼50 nm silver nanoparticles that connected with each other to form 
symmetrical leaves on branches. The length of an individual dendrite varied from 1 to 5 
μm. (Figure 2.6) The UV-Vis absorption of silver dendrites exhibits a wider range of 
wavelengths from 400-800 nm. It shows that the silver dendrites could accommodate a 
broad selection of laser excitation sources for SERS experiments compared to other 
different silver nanostructures with optimum absorption around 400-500 nm. 
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Figure 2.6 SEM images of silver dendrites.119  
 
2.3.3 SERS application 
SERS clearly presents itself as a highly versatile tool that provides complex chemical 
fingerprints from a wide range of biological or chemical agents. Comparing with other 
molecular detection and characterization techniques, the advantages of SERS are: (1) 
Rich “fingerprint” information based on chemical structure; (2) Highly sensitivity and 
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selectivity, even a single molecule detection; (3) Rapid detection requiring less than 1 
minute for each measurement; (4) The small Raman scattering cross-section of water 
allow vibrational information to be obtained in their native aqueous environment; (5) The 
ability to quench fluorescence;  (6) The capacity to be used with or without optical labels. 
Hence, it has been rapidly developed as a powerful tool for molecular detection and 
characterization, with applications in biology, medicine, materials science, biosensor and 
electrochemistry.
36–38
 The biomedical application is the most demanding SERS 
application, since SERS can provide rich biochemical information, such as proteins, 
peptides, nucleic acids, glucose, lipids and cells, and has been widely accepted as a 
routine bioanalytical characterization methodology.
39,120–123
 Furthermore, SERS is also 
used in detection of diseases in vitro and in vivo, including various cancers, diabetes, 
Alzheimer’s disease, and Parkinson’s disease.124–127  
 
SERS has been also reported to study ligand–protein interactions by dye-labeling 
methods and label-free methods. The dye-labeling methods need specially designed 
Raman reporter labeled silver or gold nanoparticle probes.
39–41
 Dye, such as brilliant blue 
R-250 (BBR) and brilliant blue G-250 (BBG) was also used as SERS label. The detection 
of Raman reporter signals indicates the interaction between ligand and protein. The label-
free methods are based on the intrinsic signals of ligand and protein. The changes in the 
Raman spectra of ligand protein incubation, either spectral pattern or intensity, is a direct 
indication of ligand-protein interaction. (Figure 2.7) It not only provides an insight into 
the mode of binding of the ligand to the protein, but also the protein conformation 
change.
42–46
 Jurasekova studied the interaction between flavonoid luteolin and human 
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serum albumin (HAS), by comparing the Raman spectra of free HAS and the HAS-
luteolin complex, changed in the intensity and the position due to the Trp residue and 
disulfide bonds were observed.
43
 He reported a different SERS sample preparation 
method to investigate the interaction between polymethoxyflavones and kappa casein.
46
 
The substrate method and solution method were utilized to prepare the SERS samples. 
Basically, for substrate method, silver (Ag) dendrites (a SERS substrate) were deposited 
on the glass and air-dried first, then the sample solution was deposited on the dried Ag 
dendrites and undergo Raman measurement. On the other hand, for the solution method, 
the Ag dendrites mixed with sample solution for a while, then the mixture of Ag 
dendrites were washed by distill water for several times to remove non-specific binding, 
lastly deposited on glass slide and air-dried. The substrate method is a simpler and faster 
way to collect the SERS ‘fingerprint’ spectrum of sample. While solution method is 
based on interaction between sample molecules and Ag dendrites. If sample could be 
bound to Ag dendrites, then the signal of sample is able be enhanced through chemical 
enhancement, otherwise, sample molecules would be washed away by water, there is 
little or no SERS signal from sample.  
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Figure 2.7 Cartoon representation of detection of protein‐ligand by SERS. The change in 
the SERS spectrum is a direct indication of ligand binding to a protein forming a protein - 
ligand complex.44 
 
Multivariate methods have been applied to SERS to identify the relevant spectral features 
that distinguish sample classes, such as discrimination between peptide, bacterial and 
viral species, and certain cancer diagnose. Principal component analysis (PCA) is a 
common method used for building linear multivariate models of complex data sets using 
orthogonal basis vectors called principal components (PCs). The first PC describes the 
maximum amount of variance present in the spectral data set, whereas successive PCs 
describe features contributing progressively smaller variance. Therefore, PCA identifies 
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and extracts major trends within a given spectral data set, which variables contribute most 
to this difference, and whether those variables contribute in the same way (i.e. are 
correlated) or independently (i.e. uncorrelated) from each other.
128
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CHAPTER 3 
BIOTRANSFORMATION OF POLYMETHOXYFLAVONES BY THE MOUSE 
AND HUMAN GUT MICROBIOME 
 
3.1 Introduction 
Polymethoxyflavones or PMFs are a unique class of citrus flavonoids bearing two or 
more methoxyl groups on their C6-C3-C6 skeleton with a carbonyl group at the position 4. 
There is a marked interest in PMFs due to their broad spectrum of biological activities, 
including anti-inflammatory, anti-carcinogenic, anti-viral, antioxidant, anti-
thrombogenic, and anti-atherogenic properties.
1–3,11,13
 Among different types of PMFs, 
nobiletin (NBT) is the major component of PMFs isolated from citrus fruits, especially in 
the peel. Particularly, NBT has been reported as a potential anti-inflammatory agent to 
inhibite LPS-induced NO generation, phorbolester-induced oxidative stress, skin 
inflammation and tumor promotion.
129
 It also exhibited synergistic anti-inflammatory 
effect with sulforaphane in decreased iNOS and COX-2 protein expression levels and 
induced heme oxygenase-1 (HO-1) protein expression, and suppressed LPS-induced 
upregulation of IL-1 mRNA levels and synergistically increased HO-1 mRNA levels.
52
 In 
term of anti-carcinogenic activity, NBT induced G1 cell cycle arrest in human breast and 
colon cancer cells,
53
  and protected the development of adenocarcinoma of the prostate in 
transgenic mice and inhibited the growth of human prostate cancer cells.
130
 Saito et al. 
reported that NBT had anti-atherogenic effects, such as enhanced both differentiation and 
lipolysis of adipocyte through activation of signaling cascades mediated by 
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cAMP/CREB.
131
 5-hydroxylnobiletin (5HN) is the most abundant hydroxylated PMFs 
isolated from citrus peel, and it can be formed via auto hydrolysis of NBT.
5
 5HN receives 
growing interests on its more potent biological activities than NBT.
5,51,132–134
 Particularly, 
5HN revealed more potent in growth inhibition of lung cancer by causing increase in sub-
G0/G1 phase and downregulating iNOS, COX-2, Mcl-1, and K-ras.
5
 The colon cancer 
was also inhibited by 5HN by inducing apoptosis and cell-cycle arrest.
51,134
 5HN also 
exhibited diverse anti-atherogenic bioactivities in inhibiting monocyte-to-macrophage 
differentiation and foam cell formation.
133
 Furthermore, anti-inflammatory study of 5HN 
demonstrated it reduced the edema formation, cell infiltration, and tissue damage in the 
inflammation induced by 12-O-tetradecanoylphorbol 13-acetate in mouse ears, along 
with the acute edema induced by carrageenan, as well as the acute phospholipase A2-
induced edema in mouse paws.
132
 
 
The biological activities of PMFs have been extensively studied in recent years, but the 
knowledge of their metabolic profile is less studied and insufficient. Dietary flavonoids 
undergo biotransformation in vivo and produce metabolites altering their bioactivities and 
pharmacological properties.
135
 Generally speaking, partial absorption of dietary 
flavonoids occurs in the small intestine, with modification by phase I (oxidation, 
reduction and hydrolysis) and phase II (glucuronidation, sulphation, and methylation) 
enzymes, and be excreted with bile back into small intestine or in the urine. Microbial 
conversion of the dietary flavonoids in the large intestine, absorption of microbial 
metabolites or fecal excretion.
78
 For dietary flavonoids that are not easily absorbed in the 
upper gastrointestinal tract, and persist to the large intestine, where they are exposed to 
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the gut microbiome community. The gut microbiome can be acted as an organ with more 
biochemical conversion than, or at least equal to liver.
25,26
 It has been reported that 
particular beneficial effects of wine polyphenolics are dependent on biotransformation by 
gut microbiome to bioactive metabolites.
136
 Soy isoflavones also showed different 
biological activities between parent compound and its microbial metabolites.
137
 Thus, the 
gut microbiome may play a crucial role in the potential health benefits of dietary 
flavonoids.  
 
PMFs have been reported to be hydroxylated and demethylated by cytochrome P450 
(CYP) in the liver.
138
 The 3’ and 4’ positions on the ring B of PMFs are the primary sites 
for biotransformation. The number and position of the hydroxyl and methoxyl groups on 
the B ring of PMFs have a great influence on the metabolism of PMFs. Several metabolic 
studies of NBT have identified its metabolites as 3’-hydroxylnobiletin, 4’-
hydroxylnobiletin, and 3’, 4’-dihydroxylnobiletin.20–22,139 Zheng also reported that major 
metabolites of 5HN found in mouse urine were 5, 3’-dihydroxylnobiletin, 5, 4’-
dihydroxylnobiletin, and 5, 3’, 4’-triihydroxylnobiletin.23 However, no group studied and 
reported the biotransformation of PMFs by gut microbiome. This paper is the first paper 
to report the biotransformation of PMFs by gut microbiome. 
 
3.2 Materials and Methods 
3.2.1 Chemicals 
Nobiletin (NBT) was purchased from Quality Phytochemicals LLC (Edison, NJ). Its 
three major metabolites in the mice have been identified as 3’-hydroxylnobiletin (M1), 
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4’-hydroxylnobiletin (M2), and 3’, 4’-dihydroxylnobiletin(M3), and synthesized 
following previous reported method as metabolites standards.
20–22,139
 5-hydroxylnobiletin 
(5HN) was obtained directly through the acid hydrolysis of NBT.
5,50
 Three major 
metabolites of 5HN in the mice have been identified as 5, 3’-dihydroxylnobiletin (M4), 5, 
4’-dihydroxylnobiletin (M5), and 5, 3’, 4’-triihydroxylnobiletin (M6), and synthesized by 
previous reported method as metabolites standard.
23
 The purity of these metabolites was 
>98%, and their chemical structures have been confirmed by MS and NMR.
21,23
 The 
chemical structure of 8 PMFs are shown in the Figure 3.1 
 
Figure 3.1 Chemical structures of nobiletin (NBT), 3’-hydroxylnobiletin (M1), 4’-
hydroxylnobiletin (M2), 3’, 4’-dihydroxylnobiletin(M3), 5-hydroxylnobiletin (5HN), 5, 
3’-dihydroxylnobiletin (M4), 5, 4’-dihydroxylnobiletin (M5), and 5, 3’, 4’-
triihydroxylnobiletin (M6). 
 
Organic solvents and all regents for isolation, chemical synthesis, and HPLC analysis 
were purchased from Fisher Scientific (Fairlawn, NJ). Ammonium acetate was a product 
of EMD Chemicals Inc. (Gibbstwon, NJ). The mixture of β-D-glucuronidase and 
sulfatase was from Sigma-Aldrich Ltd. (Castle Hill, NSW, Australia) 
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3.2.2 Animal experiments 
The protocol for the animal experiment was approved by Institutional Animal Care 
(permission number, 2011-0066) and Use Committee of the University of Massachusetts 
Amherst. The CD-1 male mice (6 week of age, weighing 18-20 g) were obtained from 
Charles River Laboratories (Wilmington, MA). Upon arrival, the animals were housed in 
a temperature-controlled environment with a 12-h light/12-h dark cycle, receiving a 
standard diet and water ad libitum. Mice were randomly divided into 3 groups of 
treatment and control, with 2 mice in each group. After 1 week acclimation, mice were 
maintained on NBT or 5HN enriched food. NBT or 5HN was mixed with semi-purified 
AIN93M (with 15% casein protein, Research Diets, Inc., New Brunswick, NJ) diet to 
formulate 0g/kg and 1g/kg NBT or 5HN enriched diet, which were orally administrated 
to the control and NBT or 5HN group correspondingly for 5 weeks, respectively. Small 
intestine (ileum part II) of treatment groups, cecum and colon of control group were 
removed, and their content were collected immediately after sacrifice. The small intestine 
content were stored at −80 °C until further analysis. The cecum and colon content were 
conducted to gut microbiome collection and incubation immediately. 
 
3.2.3 Preparation of anaerobic culture medium 
The anaerobic techniques of Hungate (1969) were used, unless specified otherwise.
140
 
The Revised Darcy Medium (RDM) was prepared as described previously,
141
 and it 
contained 2.0 g/L NaH2PO4, 10.0 g/L K2HPO4, 1.0 g/L (NH4)2SO4, 1.0 g/L L-cysteine 
hydrochloride monohydrate, 5 g/L Bacto Yeast Extract, and 10 ml/L Bach’ s trace 
element (BTE) solution. Resazurin (1 mg/L) was added as an oxidation/reduction 
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indicator, and 5 g/L pectin was added to RDM. The pH was adjusted to 7.2, and the final 
volume was adjusted to 1000 mL with distilled water. The medium were sterilized by 
autoclaving at 121°C for 20 min.  
 
3.2.4 Mouse and human gut microbes collection and incubation 
After sacrificing control group mice, the cecum and colon content were collected and 
suspended into 10 mL culture medium with 0.4 mL DMSO on the Hungate. Fresh fecal 
samples were obtained from 3 healthy free-living volunteers with no dietary restrictions 
(1 female, 2 male; aged 20s - 50s; Caucasian, Asian, and Hispanic; no recent history of 
gastrointestinal disease). Fresh human feces (0.5 g) of three volunteers were weighed and 
suspended into 10 mL culture medium with 0.4 mL DMSO on the Hungate. Then the 
mouse and human gut microbiome suspension were homogenized adequately using a 
vortex-mixer, and 1 mL of aliquots was stored at -80°C until use. 
 
1 mL aliquots of mouse or human gut microbiome suspension was inoculated into 9 mL 
culture medium, and anaerobically incubated at 37°C for 24 h.  
 
3.2.5 Exposure of PMFs to the mouse and human gut microbiome 
3.2.5.1 Exposure of mouse small intestine content fed with NBT or 5HN to the 
mouse and human gut microbiome 
The small intestine content of 2 mice with NBT treatment were combined together, and 
were extracted by butanol 3 times. The combined butanol extracts were dried under 
vacuum, and dissolved in DMSO to achieve final total concentration of NBT with its 
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metabolites (free form + conjugated form) was 10 mM – 15 mM. The small intestine 
content stock solution from mouse fed with NBT is named as SI-NBT. Same extraction 
procedure was applied to the small intestine content stock solution from mouse fed with 
5HN, and it was named as SI-5HN. 10 μL SI-NBT or SI-5HN was added to 9.5 mL 
medium, followed by addition of 0.5 mL of gut microbiome inoculum as treatment group. 
10 μL SI-NBT or SI-5HN was added to 10 mL medium without gut microbiome 
inoculum as positive control group. 10 μL DMSO was added to 9.5 mL medium, 
followed by addition of 0.5 mL of gut microbiome inoculum without SI-NBT or SI-5HN 
as negative control group. The mixture was incubated at 37°C for 24 hours in anaerobic 
chamber containing 80% N2, 10% CO2, and 10% H2. All the groups were prepared in 
triplicates. 
 
3.2.5.2 Exposure of individual PMFs to human gut microbiome 
10 μL 10 mM individual NBT and its synthesized metabolites (M1-M3); individual 
synthesized 5HN and its metabolites (M4-M6) were added to 9.5 mL medium, followed 
by addition of 0.5 mL of gut microbiome inoculum as treatment group. 10 μL 10 mM 
individual NBT and its synthesized metabolites (M1-M3); individual synthesized 5HN 
and its metabolites (M4-M6) were added to 10 mL medium without gut microbiome 
inoculum as control group. The mixture was incubated at 37°C for 24 h in anaerobic 
chamber containing 80% N2, 10% CO2, and 10% H2. All the groups were prepared in 
triplicates. 
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3.2.6 Sample preparation for HPLC analysis 
3.2.6.1 Mouse small intestine content fed with NBT or 5HN fermentation sample 
Two aliquots of fermentation samples (200 μL each) from the control groups or treatment 
group were added into 200 μL 60% methanol, and centrifuged at 8000 rpm for 5 min. 
Then methanol in sample supernatant was dried under vacuum. The first aliquot was 
incubated with 20 μL of mixed β-D-glucuronidase (250 U) and sulfatase (1 U) solution at 
37 °C for 45 min, and the second aliquot was incubated with 20 μL of distilled water at 
37 °C for 45 min. The samples were then extracted with 400 μL of ethyl acetate for 3 
times. The combined ethyl acetate extracts were dried under vacuum, and dissolved in 
100 μL of mobile phase A for HPLC analysis. 
 
3.2.6.2 Individual PMFs fermentation sample 
200 μL fermentation samples from the control group and treatment group were added into 
200 μL 60% methanol, and centrifuged at 8000 rpm for 5 min. Then methanol in sample 
supernatant was dried under vacuum. The samples were then extracted with 400 μL of 
ethyl acetate for 3 times. The combined ethyl acetate extracts were dried under vacuum, 
and dissolved in 100 μL of mobile phase A for HPLC analysis. 
 
3.2.7 HPLC analysis of cultured PMFs 
Quantification of biotransformation of PMFs by mouse and human gut microbiome were 
conducted by an HPLC with an electrochemical detector and UV-vis detector using our 
previously published method with modification.
76,142
 The CoulArray
®
 HPLC system 
(Chelmsford, MA) consisted of a binary solvent delivery system (model 584), an 
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autosampler (model 542), a UV-vis detector(model 526; Waters, Milford, MA) and a 
CoulArray
® 
Multi-Channel EC detector (model 6210; Waters, Milford, MA). Instrument 
control and data processing were performed with CoulArray 3.06 software (Chelmsford, 
MA). Ascentis RP-Amide RP HPLC column (15 cm × 4.6m id, 3 µm; Sigma-Aldrich, 
MO) was used. Flow rate was set to 1.0 mL/min, and the temperature of auto sampler 
was set to 4 °C. The injection volume was 30 µL. The UV wavelength of UV-vis detector 
was set at 330 nm. The electrochemical detector cells were set at the detecting potentials 
of 100, 200, 300, and 400 mV. The mobile phases consisted of A (75% water, 20% 
acetonitrile, 5% tetrahydrofuran, and 25 mM ammonium acetate, pH 3.0) and B (50% 
water, 40% acetonitrile, 10% tetrahydrofuran, and 50 mM ammonium acetate, pH 3.0). 
The linear solvent gradient consisted of 10% B at 0 min, 100% B at 20 min, and 100% B 
at 30 min.  
 
Synthesized compounds (M1-M3) were used as standards to identify and quantify the 
metabolites of NBT in the fermentation samples. Synthesized compounds (M4-M6) were 
used as standards to identify and quantify the metabolites of 5HN in the fermentation 
samples. 
 
Standard curves of the standard compounds were constructed by plotting concentrations 
(x axis, µM) versus peak areas (y axis, µC). Quantification of the metabolite in 
fermentation sample was performed by comparing their peak areas with the standard 
stock solutions of serious concentrations. For NBT, M1, M2, M3, linear calibration 
curves (correlation coefficient, r
2
>0.9990) can be obtained within the range of 0.5 – 10 
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µM, and their regression equations are as follows: y = 0.139x+0.0433 (r
2
= 0.9994), y = 
1.5748x+0.505 (r
2
= 0.9990), y = 2.0025x+0.1996 (r
2
= 0.9998), y = 2.5992x+0.3401 (r
2
= 
0.9998), respectively. For 5HN, M4, M5, M6, linear calibration curves (correlation 
coefficient, r
2
>0.9990) can be obtained within the range of 0.5–10 µM, and their 
regression equations are as follows: y = 2.0277x+0.4546 (r
2
= 0.9990), y = 2.593x+0.1926 
(r
2
= 0.9999), y = 2.2196x+0.1181 (r
2
= 0.9999), y = 2.6472x+0.1466 (r
2
= 0.9999), 
respectively.  
 
The HPLC chromatograms of NBT and its metabolites standards, 5HN and its 
metabolites standards are shown in the Figure 3.2. NBT is detected by UV detector at 
330 nm, while 5HN and M1 – M6 are detected by electrochemical detector. The retention 
time of NBT is 12.3 min, M1 and M2 are detected at potential 400 mV, and the retention 
time is 10.3 min and 11.0 min, respectively; M3 is detected at potential 200 mV, and the 
retention time is 9.17 min. 5HN, M4, and M5 are also detected at potential 400 mV, the 
retention time is 20.9 min, 18.3 min and 19.7 min, respectively; M6 is detected at 
potential 200 mV, and the retention time is 16.8 min. 
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Figure 3.2 HPLC chromatograph of  nobiletin (NBT), 3’-hydroxylnobiletin (M1), 4’-
hydroxylnobiletin (M2), 3’, 4’-dihydroxylnobiletin(M3), 5-hydroxylnobiletin (5HN), 5, 
3’-dihydroxylnobiletin (M4), 5, 4’-dihydroxylnobiletin (M5), and 5, 3’, 4’-
triihydroxylnobiletin (M6) standards. NBT was showed in dash line, and 5HN, M1-M6 
were showed in solid line. 
 
3.2.8 Cell viability assay 
The inhibitory effects of NBT/5NN mouse gut microbiome fermentation sample on colon 
cancer cells were established by our previously published method.
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 Human colon cancer 
cell line HCT116 (1500 cells/well), HT29 (2000 cells/well) were seeded in 96-well 
plates. After 24 h, cells were treated with serial concentrations of different fermentation 
samples in 200 μL of serum complete media. At 48 h, cells were subject to 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Briefly, media 
were replaced by 100 μL fresh media containing 0.5 mg/mL of MTT (Sigma-Aldrich, St. 
Louis, MO). After 1 h of incubation at 37 °C, MTT-containing media were removed and 
the reduced formazan dye was solubilized by adding 100 μL of DMSO to each well. 
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After gentle mixing, the absorbance was monitored at 570 nm using a plate reader 
(Sepectramax m2e, Molecular devices, Sunnyvale, CA). Cell viability was expressed as 
the percentage of absorbance of treated cells relative to that of the control (percentage of 
control). 
 
3.3 Results and discussions 
3.3.1 Biotransformation of SI-NBT/SI-5HN by the mouse gut microbiome 
It is very common that flavonoids and their metabolites are in their conjugated forms as 
glucuronides and/or sulfates after phase II metabolism occurring mainly in the liver. 
Therefore, we compared the levels of NBT/5HN and its three metabolites in the small 
intestine content treated with or without a mixture of β-glucuronidase and sulfatase. The 
treatment of β-glucuronidase and sulfatase converted the glucuronides and/or sulfates of 
NBT/5HN and its metabolites to their free forms.  
 
The level of NBT and its metabolites change after anaerobic fermentation by mouse gut 
microbiome were shown in the Figure 3.3. In the negative control group (without adding 
SI-NBT, but adding mouse gut microbiome), with or without β-glucuronidase and 
sulfatase treatment, no level of PMFs were detected. Hence, mouse gut microbiome could 
not produce PMFs by itself. In the positive control group (without adding mouse gut 
microbiome but adding SI-NBT) in Figure 3.3A, 69.24% of NBT and its 3 metabolites 
were mainly in their conjugated forms as glucuronides and/or sulfates. Particularly, there 
was no conjugated form of NBT. The ratio of conjugated form to free form of M1, M2, 
and M3 was 7.08, 2.34, and 5.74, respectively. In addition, M2 (conjugated form + free 
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form) was major metabolites, accounting for 75.18% in the total metabolites, then 
following by M3 (15.52%) and M1 (8.86%), in the small intestine after phase II 
metabolism. Li and Yasuda also reported that the major NBT metabolite in mouse urine 
was M2.
20,21
 In the Figure 3.3B, 57.39% of 5HN and its metabolites were presence as 
conjugates as glucuronides and/or sulfates in small intestine. Unlike NBT, 5HN could 
form conjugates since it has hydroxyl group at the position 5. The ratio of conjugated 
form to free form of M4, M5, and M6 was 1.85, 1.26, and 3.72, respectively. M5 
(conjugated form + free form) was major metabolites of 5HN in small intestine after 
phase II metabolism, accounting for 38.40% of total 5HN and its metabolites, then 
following by M4 (21.39%), and M6 (9.41%). By studying the urine metabolites of 5HN 
in mice, Zheng found that 5HN could be demethylated at both position 3’ and 4’, and 
demethylation at the position 4’ was much more preferred.23 
 
However, after anaerobic fermentation by the mouse gut microbiome, no matter NBT or 
5HN, the amount of free form of their metabolites dramatically increased, and almost 
reached to same level of NBT/5HN metabolites (free form + conjugated form) in the 
control group. When the fermentation groups treated with mixture of β-glucuronidase and 
sulfatase, no further increased amount of free form of NBT/5HN metabolites were 
observed (Figure 3.4). Those results demonstrated that the conjugated form of NBT/5HN 
metabolites in small intestine were fully converted to free form by the mouse gut 
microbiome. The mouse gut microbiome can largely cleave the glucuronide and sulfate 
conjugates, deconjugate them to free form. For 2 mice, there were no significant 
difference between each other in term of total amount of NBT/5HN metabolites, and ratio 
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of each metabolite. The removal of the polar conjugating groups by the gut microbiome 
allows NBT/5HN metabolites to be reabsorbed and returned to its site of action. Thus, the 
gut microbiome may prolong the action of PMFs by allowing their enterohepatic 
circulation to continue.  
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Figure 3.3 Metabolic profile of mouse gut microbiome A) small intestine content of mice  
fed with NBT (SI-NBT); B) small intestine content of mice fed with 5HN (SI-5HN). 
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Figure 3.4 Metabolic profile of mouse gut microbiome without or with β-D-
glucuronidase and sulfatase treatment. A) Small intestine content of mice fed with NBT 
(SI-NBT); B) Small intestine content of mice fed with 5HN (SI-5HN). Enzyme -: without 
β-D-glucuronidase and sulfatase treatment; Enzyme +: with β-D-glucuronidase and 
sulfatase treatment. 
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3.3.2 Biotransformation of PMFs by the human gut microbiome 
3.3.2.1 Biotransformation of SI-NBT, individual NBT and its metabolites (M1-M3) 
by human gut microbiome 
Similarly, there was no PMFs obtained with or without β-glucuronidase and sulfatase 
treatment in the negative control group without adding SI-NBT and SI-5HN, but adding 
gut microbiome. The human gut microbiome could not produce PMFs by itself either. 
 
The level of NBT and its metabolites change after anaerobic fermentation by human gut 
microbiome were also investigated (Figure 3.5). By further treating human gut 
microbiome fermentation sample with β-D-glucuronidase and sulfatase, no increasing 
level of free form was observed. (Figure 3.6) First of all, similar to the mouse gut 
microbiome, the human gut microbiome could deconjugate the glucuronide and sulfate 
conjugates to free form. Even though the mouse gut microbiome were collected from 
cecum and colon content directly, while the human gut microbiome were collected from 
human feces. The composition of gut microbiome of mouse and human is different,106 
and the different species dominate in feces, different parts of cecum and colon.143,144 
However, in term of deconjugation, no matter mouse or human, microbiome from cecum, 
colon or feces exhibited same ability. 
 
Secondly, as we discussed in the section 3.3.1, the major metabolite of NBT in small 
intestine is M2 (75.18%), then following by M3 (15.52%), and M1 (8.86%) had lowest 
portion. After anaerobic fermented with human subject 1 gut microbiome, there was no 
significant change of the ratio of every metabolite compared to control. 75.85% of M2, 
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16.73% of M3, and 6.29% of M1 were observe in human subject 1 fermentation sample, 
respectively. Interestingly, after anaerobic fermented with human subject 2 and 3 gut 
microbiome, M3 became major metabolite instead of M2. Particularly, the amount of M1 
and M2 decreased largely in the human subject 2 fermentation sample, from 6.29% to 
0.54% for M1, and from 75.85% to 2.61% for M2. Whereas M3 increased from 16.73% 
to 95.83%. The results showed that almost both of M1 and M2 were converted to M3 by 
human subject 2 gut microbiome. In human subject 3 fermentation sample, M2 dropped 
to 34.37%, while M3 raised to 57.40%, hence, about half of M2 was converted to M3 by 
human subject 3 gut microbiome. M1 and M2 both have one hydroxyl group in the 
different position of B ring, while M3 has two hydroxyl groups in the B ring. Therefore, 
other than deconjugation, human gut microbiome also caused demethylation at certain 
positions of flavonoid core structures, such as 3' and 4' positions in the B ring. 
 
Figure 3.5 Metabolic profile of human gut microbiome with small intestine content of 
mouse fed with NBT. 
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Figure 3.6 Metabolic profile of human gut microbiome with small intestine content of 
mouse fed with NBT without or with β-D-glucuronidase and sulfatase treatment. Enzyme 
-: without β-D-glucuronidase and sulfatase treatment; Enzyme +: with β-D-glucuronidase 
and sulfatase treatment. 
 
In order to further investigate the demethylation by human gut microbiome, the 
individual NBT, and its synthesized metabolites M1, M2, M3 (free form) were anaerobic 
fermented with human gut microbiome (Figure 3.7). When NBT or M3 incubated with 
human gut microbiome, human subject 1 and human subject 3 fermentation sample 
showed the similar level of NBT or M3 as control (Figure 3.7A&B). It suggested that 
both NBT and M3 could not be demethylated by human subject 1 and human subject 3 
gut microbiome. On the other hand, human subject 2 gut microbiome revealed different 
demethylation ability. Level of NBT decreased from 8.26 µM to 2.95 µM, and level of 
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M3 increased from 0 µM to 1.35 µM. Deduction of M3 from 11.36 µM to 4.01µM was 
also observed in the human subject 2 fermentation sample. This results indicated that 
human subject 2 gut microbiome could demethylate NBT to M3 or other PMFs and small 
molecules, and M3 to other PMFs or small molecules because the total level of PMFs 
decreased. Koga et al. reported that NBT could be metabolized to 4′- hydroxylnobiletin, 
7- hydroxylnobiletin, 6- hydroxylnobiletin, 3′, 4′-di hydroxylnobiletin and 6,7-
dihydroxylnobiletin by liver microsomes.
80,81
 There was no paper reported directly that 
human gut microbiome transferred PMFs to small molecules, but there was evidence that 
flavonoids were transferred by human gut microbiome to small molecules, such as 
quercetin and rutin to 3,4-dihydroxyphenylacetic acid; luteolin to 3-(3,4-
dihydroxyphenyl)propionic acid; and apigenin and naringenin to 3-(4-
hydroxyphenyl)propionic acid by cleaving the C ring of flavonoids.
90,145
 When M1 
incubated with human gut microbiome, all human subject fermentation samples showed 
the reduced level of M1, and increased level of M3 compared to control (Figure 3.7C). 
However, the demethylation degree varied in different human subjects. Human subject 1 
only transferred 4.21% M1 to M3, and human subject 3 transferred 85.96% M1 to M3. 
Particularly, in human subject 2 fermentation sample, there was no M1 but 4.86 µM M3 
was detected, which suggested that human subject 2 gut microbiome transferred 100% 
M1 to M3, and it further transferred M1 to other PMFs, or small molecules. Similar trend 
of demethylation by human gut microbiome were observed when it incubated with M2 
(Figure 3.3D). Human subject 1 only demethylated small portion (3.19%) of M2 to M3. 
Both human subject 2 and human subject 3 could fully demethylate M2 to M3, and 
human subject 2 further transferred M3 to other PMFs, or small molecules. When 
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comparing M1 and M2 metabolic profile by human subject 2 gut microbiome, less M3 
was detected in M2 fermentation sample which indicated more M2 was metabolized than 
M1; comparing M1 and M2 metabolic profile by human subject 3 gut microbiome, M2 
was fully metabolized to M3, whereas M2 was partially metabolized to M3 by human 
subject 3 gut microbiome. Since M1 has one hydroxyl group at the position 3’, whereas 
M2 has one hydroxyl group at the position 4’, it suggested that compared to 3’ position, 
4’ position was much more preferred to be demethylated by human gut microbiome. 
Overall, in term of demethylation, human gut microbiome had no effect or very limited 
effect on NBT and M3. M1 and M2 can be demethylated to M3. The degree of 
demethylation varied in different human subject gut microbiome that human subject 1 
had lowest capacity, while human subject 2 had highest capacity.  
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Figure 3.7 Metabolic profile of human gut microbiome with A) NBT; B) M3; C) M1; D) 
M2. Control is PMFs only without human gut microbiome. H1 represents PMFs 
anaerobically incubated with human subject 1 gut microbiome, H2 represents PMFs 
anaerobically incubated with human subject 2 gut microbiome, H3 represents PMFs 
anaerobically incubated with human subject 3 gut microbiome. 
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3.3.2.2 Biotransformation of SI-5HN, individual 5HN and its metabolites (M4-M6) 
by human gut microbiome 
The metabolic profile of human gut microbiome with small intestine content when mouse 
fed with 5HN was shown in the Figure 3.8. By further treating human gut microbiome 
fermentation sample with β-D-glucuronidase and sulfatase, no increasing level of free 
form was observed. (Figure 3.9) First of all, the glucuronide and sulfate conjugates of 
5HN after phase II metabolism could be deconjugated to free form by human gut 
microbiome. Secondly, as we discussed in the section 3.3.1, the major metabolite of 5HN 
in small intestine content is M5 (38.4%), then following by M4 (21.39%), and M6 
(9.41%) had lowest portion. After anaerobic fermentation with human subject 1 gut 
microbiome, the ratio of every metabolite (M4-M6) was very similar to control that M5 
(39.8%) was major metabolites, then following by M4 (13.7%), and M6 (8.7%). 
However, human subject 2 and 3 gut microbiome showed different metabolic profile that 
M6 became major metabolite instead of M5. Particularly, the amount of 5HN, M4 and 
M5 decreased largely in human subject 2 fermentation sample, from 30.8% to 26.31% for 
5HN, from 21.39% to 0% for M4, and 38.4% to 0.85% for M5. While, M6 increased 
from 9.41% to 72.84%. Additionally, large reduction of total amount of 5HN and its 
metabolites were observed. The total level of 5HN and its metabolites (conjugates + free) 
in control was 12.69 µM, while the total level of 5HN and its metabolites in human 
subject 2 fermentation sample was 6.59 µM. The results suggested that 5HN, M4 and M5 
could be converted to M6. 5HN and its metabolites were further metabolized to other 
PMFs or small molecules by human subject 2 gut microbiome. In human subject 3 
fermentation sample, M4 and M5 dropped to 0.05% and 1.09%, while M6 raised to 
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63.37%, hence, M4 and M5 were converted to M6 fully by human subject 3 gut 
microbiome. M4 and M5 both have one hydroxyl group in the different position of B 
ring, while M6 has two hydroxyl groups in the B ring. Therefore, other than 
deconjugation, human gut microbiome also caused demethylation at certain positions of 
flavonoid core structures, such as 3' and 4' positions in the B ring. 
 
Figure 3.8 Metabolic profile of human gut microbiome with small intestine content of 
mouse fed with 5HN. 
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Figure 3.9 Metabolic profile of human gut microbiome with small intestine content of 
mouse fed with 5HN without or with β-D-glucuronidase and sulfatase treatment. Enzyme 
-: without β-D-glucuronidase and sulfatase treatment; Enzyme +: with β-D-glucuronidase 
and sulfatase treatment. 
 
In order to further investigate the demethylation by human gut microbiome, the free form 
of 5HN and its metabolites M4, M5, M6 individual were anaerobic fermented by human 
gut microbiome separately (Figure 3.10). When 5HN incubated with human gut 
microbiome, no significant change in level of 5HN was observed in the human subject 1 
fermentation sample compared to control (Figure 3.10A). While level of 5HN decreased 
from 10.52 µM to 0.58 µM, and 8.58 µM in the human subject 2 and human subject 3 
fermentation sample, respectively. There were deduction of M6 when human gut 
microbiome incubated with M6, but the degree of deduction were different in those 
fermentation samples (Figure 3.10B). M6 decreased from 8.19 µM to 3.53 µM, 1.51µM 
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and 3.01µM in the human subject 1, 2, 3 fermentation sample, respectively. Thus, unlike 
NBT and M3 which had no or limited demethylation by human gut microbiome, 5HN 
and M6 could be demethylated or metabolized. The chemical structure difference of NBT 
and 5HN, M3 and M6, is that 5HN and M6 have hydroxyl group at the position 5, while 
NBT and M3 have methoxyl group at the position 5 (Figure 3.1). The hydroxyl group at 
the position 5 resulted in 5HN and M6 more active for demethylation and bioconversion 
by human gut microbiome. When M4 and M5 incubated with human gut microbiome, the 
demethylated effect on M4 and M5 varied by different human subjects (Figure 
3.10C&D). Human subject 1 had no or limited effect on demethylation. The level of M5 
slightly decreased from 9 µM to 7.39 µM, and 0.09 µM M6 was detected. In the human 
subject 2 fermentation sample, both M4 and M5 level dropped dramatically, and 
increasing level of M6 was detected. At the same time, the total level of PMFs after 
fermentation was obviously less than control, especially in M5 sample. It suggested that 
human subject 2 gut microbiome not only demethylated M4 and M5 to M6, but also 
transferred M1 to other PMFs, or small molecules. Except M4 – M6, Zheng also 
identified new metabolites, 5, 6-dihydroxylnobiletin, 5, 7-dihydroxylnobiletin, 5, 7, 3'-
trihydroxylnobiletin, 5, 7, 4'-trihydroxylnobiletin, and 5, 7, 3', 4'-tetrahydroxylnobiletin 
from mouse urine after mouse administrated. Lack of standards so far, we could not 
confirm whether the PMFs metabolites by human gut microbiome were same PMFs from 
urine. Similar trend of demethylation of M4 and M5 were observed when they incubated 
with human subject 3 gut microbiome. It could partially demethylated M4 and M5 to M6, 
and further transferred M5 to other PMFs, or small molecules. Additionally, less amount 
of M5 was observed compared to M4 in fermentation samples, which suggested that 
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compared to 3’ position, 4’ position was much more preferred to be demethylated by 
human gut microbiome. In summary, 5HN and M4-M6 can be demethylated and 
metabolized by human gut microbiome. The effect on demethylation showed high 
variation among different human gut microbiome.  
 
There were no significant difference between each other for 2 mice, in term of total 
amount of NBT/5HN metabolites, and ratio of each metabolite (Figure 3.3). On the other 
hand, inter-individual variations were observed in different human subjects (Figure 3.5, 
3.7, 3.8, 3.10). All human gut microbiome could largely cleave conjugates to free form, 
while the degree of demethylation varied among 3 human subjects as we discussed. 3 
human volunteer is Caucasian, Asian, and Hispanic, respectively, 2 male and 1 female, 
aged from 20s – 50s. It is not surprised because gut microbiome composition varies 
substantially among individuals, and is influenced by genotype, physiological condition 
of host, diet, lifestyle and environment.
88,146,147
 Consequently, each gut microbial 
community can be expected to display its own characteristic metabolic profile. The 
bioactivities of PMFs or other dietary flavonoids varies in different human, thus shows 
different health beneficial effects. Strong inter-individual variability displayed in 10 
human subjects in term of specific dietary polyphenol metabolite profile differing in 
composition and time courses as well as levels of these metabolites was also reported by 
Gross.
148
  Nevertheless, large sample of human volunteers are needed to support the 
hypothesis at this point. 
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Figure 3.10 Metabolic profile of human colonic microbiome with A) 5HN; B) M6; C) 
M4; D) M5. Control is PMFs only without human gut microbiome. H1 represents PMFs 
anaerobically incubated with human subject 1 gut microbiome, H2 represents PMFs 
anaerobically incubated with human subject 2 gut microbiome, H3 represents PMFs 
anaerobically incubated with human subject 3 gut microbiome. 
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3.3.3 Inhibitory effects on human colon cancer cells 
Colon cancer is one of the leading causes of cancer death in the United States, and there 
is convincing evidence for protective effects of flavonoids from fruit and vegetables 
against colon cancer.
149
 Thus, we studied the effects of gut microbial metabolites of NBT 
and 5HH on the growth of human colon cancer cells; HCT 116 and HT29 cell lines.  
 
As shown in the Figure 3.11, the isolates from small intestine of mouse fed with NBT 
after mouse gut microbiome fermentation, demonstrated a dose-dependent inhibition on 
the growth of 2 human colon cancer cells. First of all, the mouse gut microbiome itself 
showed no inhibitory effect on 2 colon cancer cells. According to HPLC analysis results 
and different tolerance of colon cancer cells to PMFs, we determined and prepared the 
full dose of SI-NBT and mouse gut microbiome treatment as 10 μM and 5 μM total 
concentration of NBT and its metabolites after SI-NBT fermented with mouse gut 
microbiome for HCT116 cell and HT29 cell, respectively, then diluted to several lower 
concentrations. Accordingly, the same concentrated fold used in SI-NBT and mouse gut 
microbiome treatment was applied in SI-NBT without mouse gut fermentation treatment 
to achieve full does. In the Figure 3.11A, at full dose of SI-NBT without mouse gut 
microbiome fermentation, only 13.5% of HCT116 cell was inhibited. On the other hand, 
35.7% of HCT cell and 63.5% of HCT116 cell were inhibited by 5 μM (half full dose) 
and 10 μM (full does) of SI-NBT with mouse gut microbiome fermentation. NBT and its 
metabolites showed higher inhibitory effects on HT29 cancer cell line compared to HCT 
116 cancer cell (Figure 3.11B). When HT29 cell treated with isolates of SI-NBT after 
mouse gut microbiome fermentation, 5 μM of total concentration of NBT and its 
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metabolites (full dose) could inhibit 51.9% of HT29 cell growth; while, full dose of 
isolates of SI-NBT without mouse gut microbiome fermentation only inhibited 21.6% of 
HT29 cell growth. Overall, SI-NBT after gut microbiome fermentation showed much 
stronger inhibitory effect on both HCT116 and HT29 colon cancer cell lines than SI-NBT 
without mouse intestinal microbiome fermentation. 
 
Figure 3.11 Inhibitory effect of SI-NBT with mouse gut microbiome fermentation on the 
growth of HCT116 (A) and HT29 (B) human colon cancer cells. Data represent mean ± 
SD (N = 6). All the results described in Section 3.3 showed statistical significance 
according to Student’s t-test (p <0.01, n = 6). 
 
Compared to NBT and its metabolites, 5HN and its metabolites exhibited much stronger 
inhibitory effect on HCT116 and HT29 colon cancer cell (Figure 3.12). Zheng reported 
that the metabolites of 5HN, M4, M5 and M6 showed stronger inhibitory effects on 
human colon cancer SW620 and SW480 cells than their parent compound 5HN. 
Particularly, M4 had IC50 value of 0.18 μM and 0.12 μM after 48 and 72 hours treatment 
on SW619 cells, and 0.5 μM on SW 480 cells.23 As shown in the Figure 3.12A, SI-5HN 
without mouse gut microbiome fermentation only inhibited 17.8% of HCT116 cell at the 
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full dose. While after mouse gut microbiome fermentation, 5 μM (half full dose) and 10 
μM (full dose) of total 5HN, and its metabolites inhibited 45.7% and 76.3% of HCT116 
cell growth. Similar to NBT and its metabolites, 5HN and its metabolites showed 
stronger inhibitory effect on HT29 cell (Figure 3.12B). After mouse gut microbiome 
fermentation, 1.25 μM of total concentration of 5HN and its metabolites inhibited 47.3% 
HT29 cell. Once the total concentration increased to 2.5 μM (half full dose), 81% of 
HT29 cells were inhibited. There was no significant increasing of inhibitory effect at full 
dose. However, SI-5HN without mouse gut microbiome fermentation only inhibited 
20.6% of HT29 cell at the full dose. In sum, SI-5HN showed much stronger inhibitory 
effect on HCT116 and HT29 cell growth after mouse gut microbiome fermentation.  
 
Mouse gut microbiome mainly cleave the PMFs conjugates to free form.  Therefore, the 
removal of the polar conjugating groups by the gut microbiome not only allows those 
metabolites to be reabsorbed and returned to its site of action, prolong the action of PMFs 
by allowing their enterohepatic circulation to continue, but also restore the active 
compound, and increased the bioactivities of metabolites.  
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Figure 3.12 Inhibitory effect of SI-5HN with mouse gut microbiome fermentation on the 
growth of HCT116 (A) and HT29 (B) human colon cancer cells. Data represent mean ± 
SD (N = 6). All the results described in Section 3.3 showed statistical significance 
according to Student’s t-test (p <0.01, n = 6). 
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CHAPTER 4 
SURFACE ENHANCED RAMAN SCATTERING CHARACTERIZATION OF 
MONOHYDROXYLATED POLYMETHOXYFLANONES 
 
4.1 Introduction 
Polymethoxyflavones (PMFs), a unique class of flavonoids mainly found in citrus fruits, 
have been reported to have a broad spectrum of beneficial bioactivities including anti-
inflammatory, anti-carcinogenic activities and anti-atherosclerosis.
5,50–52,134,150
 More than 
20 different PMFs have been isolated and identified from citrus plants.
2
 Characterization 
of different PMFs is critical to further understand and apply these compounds as 
functional food ingredients in food and beverage products. Many analytical methods have 
been reported to separate and characterize those PMFs from citrus fruits, e.g. capillary 
electrochromatography,
66
 flashing chromatography,
62,73
 thin-layer chromatography 
(TLC),
58,77
 supercritical fluid chromatography (SFC),
60,67
 gas chromatography (GC),
68
 
and high performance liquid chromatography (HPLC).
2,59,61,63,64,69–71,74–76
 Mass 
spectrometry (MS) and nuclear magnetic resonance (NMR) were usually conducted after 
chromatographic system for structural identification and elucidation.
61,68,69,71,77
 
 
There are growing interests on using an innovative analytical method, surface enhanced 
Raman spectroscopy (SERS), to characterize PMFs and other flavones.
151–158
 SERS is a 
novel analytical method that combines Raman spectroscopy and nanotechnology. Raman 
spectroscopy is a vibrational spectroscopy providing rich characteristic information of 
molecular structure. It is caused by the interaction between energy change of inelastically 
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scattered incident light and vibrational mode of chemical bonds within sample. However, 
only 1 in 10
6-8
 of photons undergoes Raman scattering, hence, the Raman scattering 
signal is relatively weak. By placing sample on or near the noble metal nanostructure, e.g. 
silver, gold or copper, can enhance the weak Raman scattering more than a million times 
through the amplification of electromagnetic fields. Due to its highly sensitive structural 
detection on a trace amount of analytes, SERS has been rapidly developed as a powerful 
tool for molecular detection and characterization, with applications in materials science, 
chemistry, engineering, bioscience and medical science.
36,37
 Compared with other 
analytical methods, the advantages of using SERS for characterizing PMFs are: 1) great 
capacity to differentiate PMFs with different chemical structures, 2) simple sample 
preparation, 3) sensitive measurement requiring a trace amount of sample, 4) rapid 
analysis. 
 
In previous studies, we have explored Raman and SERS for characterizing some PMFs, 
including nobiletin, 5-hydroxylnobiletin and tangeretin, to demonstrate the superior 
capacity of SERS for characterization and differentiation among different PMFs, in 
comparison with HPLC.
151,152
 Particularly, we found the number of the hydroxyl groups 
played an important role in interaction with silver (Ag) dendrites, the SERS substrate 
used in these studies.
46,152
 However, the molecular behaviors of PMFs interacting with 
Ag substrate is still poorly understood, which significantly limits the development and 
applications of SERS for further analyzing the different PMFs. In this study, we aimed to 
focus on monohydroxylated PMFs to elucidate the role of the hydroxylation position on 
the interaction between PMFs and Ag, and its relationship with the SERS enhancement 
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and characterization. Three monohydroxylated PMFs were studied, namely 3-
hydroxylnobiletin (3HN), 4-hydroxylnobiletin (4HN), and 5-hydroxylnobiletin (5HN). 
3HN and 4HN are the metabolites of nobiletin showed as M1 and M2 in the section 3.2.1. 
Those monohydroxylated PMFs exhibited much stronger bioactivities than nobiletin. 
3HN and 4HN revealed more potent anti-inflammatory activity,
22 
and 5HN showed 
stronger inhibitory effect on different cancer cells.
2,50
 Their enhanced bioactivities are 
believed to correlate with their unique chemical structures; however, the chemical 
mechanism remains uncovered. For the first time, this study aims to use SERS to 
characterize three monohydroxylated PMFs and determine the role of hydroxylation 
position in the PMF molecules. Understanding the SERS behaviors of these PMFs will 
further advance the utilization of SERS for the characterization of different flavonoids in 
future.  
 
4.2 Materials and methods 
4.2.1 PMF structures 
Three monohydroxylated PMFs, 3-hydroxylnobiletin (3HN), 4-hydroxylnobiletin 
(4HN), and 5-hydroxylnobiletin (5HN) are shown in the Figure 3.1. The major 
difference is the position of hydroxyl group in the molecule. They were chemically 
synthesized from nobiletin that was isolated from sweet orange as previously 
described.
5,21
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4.2.2 SERS sample preparation and Raman instrumentation 
Ag dendrites were synthesized through a simple displacement reaction involving both 
zinc and silver nitrate in accordance to a previously published method.
119
 The PMFs 
stock solutions were 20 mM in DMSO (Thermo Scientific). 3HN and 4HN were diluted 
by methanol (Thermo Scientific) to 0.05, 0.1, 0.5, 1, 2, 3 mM, and 5HN was diluted by 
methanol to 0.005, 0.01, 0.05, 0.1, 0.5, 1 mM due to its poor solubility in methanol. 500 
µL serial concentrations of PMFs solutions incubated with 10 µL Ag dendrites for 30 
minutes under consistent orbital rotation at room temperature. The Ag mixture was 
washed by double-distilled water 3 times to remove unspecific binding, and then it was 
deposited onto a glass slide and air dried for Raman measurement. 
 
The SERS spectra of each sample were collected using a DXR Raman microscope 
(Thermo Scientific) with a 780 nm excitation laser and a 10× objective confocal 
microscope (3 μm spot diameter and 5 cm-1 spectral resolution). The Raman 
measurement was taken with 3 mW of laser power and a 50 µm slit aperture for 2 
seconds scanning time. 8 spectra were collected randomly from each sample within 400- 
2000 cm
-1
 range using the Thermo Scientific OMNIC software. 
 
TQ analyst software, version 8.0 (Thermo Fisher Scientific), was conducted to analyze 
the data obtained from the DXR Raman microscope. Second derivative transformation 
and smoothing (9 nm segment length and 9 nm gap between segments) were achieved to 
separate overlapping bands and yield spectral noise.
159
 Principal component analysis 
(PCA) was applied to analyze the variance of spectral data, and it provided variance 
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within a class and between different classes. The PC score revealed the percentage of 
data variance. A larger percentage demonstrated more variance within data. In general, if 
there is no overlap between two clusters of sample, samples are significantly different. 
4.2.3 HPLC sample preparation and HPLC instrumentation 
HPLC analysis was conducted to directly quantify the concentration difference of PMFs 
before and after incubating with Ag dendrites. The same PMFs stock solution was diluted 
to 0.005 mM by methanol as the group before incubation. 100 μL PMFs solution (0.005 
mM) was incubated with 5 μL Ag dendrites overnight under consistent orbital rotation at 
room temperature. After centrifugation, the supernatant of PMFs solution was considered 
as the group after incubation. Three replicates of samples were prepared for HPLC 
analysis. 
 
The quantitative difference of PMFs before and after incubation with Ag dendrites was 
determined by an HPLC with an electrochemical detector using previously published 
method described in the section 3.2.7. 
 
4.3 Results and discussions 
4.3.1 Determination of the dose dependent curve of SERS enhancement 
The raw SERS spectra of 3 PMFs were showed in the Figure 4.1. The SERS band 
wavenumbers were tabulated in the Table 4.1, along with the assigned brief description 
of the major vibrational mode.
153,157,158 
Even through those 3 PMFs shared very similar 
chemical structure, they exhibited their own characteristics bands. Those 3 PMFs spectra 
showed similar trend of the region corresponding to Ring A, B, C deformation at 500 - 
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750 cm
-1
, and C=O stretch at 1550 – 1650 cm-1. The major differences were in the 1100 – 
1500 cm
-1
 region by appearance of different O–H bend due to the different position of 
hydroxyl group. According to the Table 4.1, the in-plane vibrational mode were observed 
in 3 PMFs, especially at the lower wavenumber range, assigned as in-plane ring 
deformation. According to the surface selection rule,
160
 when adsorbed perpendicularly, 
the in-plane bending modes of the molecules are more enhanced than the out of plane 
bending modes. This indicated that all 3 PMFs were interacted perpendicularly with 
respect to the Ag surface. 
 
 
 
. 
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Wavenumber/ cm
-1
 Description of modes 
3HN 4HN 5HN 
--- --- 446 Ring C and B, C-C bend (ip) 
535 529 518 Ring A, B, C, C-C deformation 
579 579 587 Ring A, B, C, C-C deformation 
619 --- --- Ring C rock (ip) 
692 684 688 Ring A, B, C, deformation (ip) 
725 729 730 Ring A, B, C, C-C deformation 
762 --- 767 Ring B breath 
--- 893 --- Ring A,B,C, deformation (ip) 
1136 1130 --- 3’ OH, 4’ OH, C-H bend 
--- --- 1144 Ring A, C-C stretch (ip) 
--- 1247 --- 4’ OH bend 
1261 1271 1265 Ring A, B, C, C-H bend (ip) 
1327 --- --- OH bend ip 
--- --- 1332 Ring A, B and C, C-C stretch 
1354 1356 ---- 3’ OH, 4’ OH bend, C-H bend (ip) 
--- --- 1384 5 OH bend  
1405 1406 --- 3'OH, 4'OH bend (ip) 
1461 1462 --- OH bend (ip); C-H bend (ip) 
1494 1487 1511 Ring B, C-H bend (ip) 
1560 1556 1575 Ring A, quinoid stretch; C=O stretch 
1575 1584 1601 Bing B, quinoid stretch 
1616 1613 1618 C=O stretch; quinoid stretch 
ip: in-plane 
Table 4.1. Wavenumbers and assignments of the SERS spectra of 3HN, 4HN and 5HN. 
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Figure 4.1 The raw SERS spectra of 3HN, 4HN and 5HN with peak assignments 
 
The raw SERS spectra of 4HN in different concentrations were shown in the Figure 4.2. 
After secondary derivative transformation and normalization based on the NO3
-
 peak 
(1070 cm
-1
) that was generated from Ag fabrication, their spectra were shown in the 
Figure 4.3. The data preprocessing helped improve the consistency and accuracy for the 
spectral comparison. It was clearly observed that with the 4HN concentration increased, 
the overall peak intensity increased rapidly at initial low concentrations (0.1 mM and 0.5 
mM). The rate of increase greatly slowed down after 1 mM. Principal component 
analysis (PCA) of 4HN at different concentrations (Figure 4.4) was used to analyze the 
variation between different concentrations. The clusters of different concentrations were 
completely separated up to 1 mM, which demonstrated that the peak intensity of these 
concentrations below 1 mM were statistically different from each other. Beyond 1 mM, 
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clusters of different concentrations overlapped, and the variance within cluster became 
large. It indicated that the difference of peak intensity between those concentrations were 
not statistically significant. Therefore, based on the SERS spectra and the PCA result, we 
defined the saturation point of 4HN to be 1 mM. The saturation happened when the Ag 
surface was covered by the molecules completely, therefore no further increase of peak 
intensity was observed when the concentration was higher than the saturation point.  
 
Figure 4.2 The raw SERS spectra of 4HN in different concentrations (0.05 – 3 mM). 
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Figure 4.3 The SERS spectra of 4HN in different concentrations (0.05 – 3 mM) after 2nd 
derivatives transformation. 
 
 
Figure 4.4 The PCA of SERS spectra of 4HN in different concentrations (0.05 – 3 mM). 
PC1 and PC2 revealed 96.26% of total variance. 
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Similar method was used to characterize the other two PMFs, namely 3HN and 5HN. The 
raw SERS spectra and spectra in second derivatives of 3HN and 5HN, and the PCA of 
3HN and 5HN were shown in the Figure 4.5 – 4.10. The saturation points of 3HN and 
5HN were determined to be 0.5 mM and 0.05 mM, respectively. Figure 4.11 summarized 
the relationship between PMFs concentrations and relative peak intensity (indicative peak 
intensity over NO3
-
 peak intensity) for the three PMFs. The indicative peak represented 
ring A, B, C deformation – assigned 3HN, 4HN, 5HN at 579 cm-1, 580 cm-1, 587 cm-1, 
respectively.
153,158
 Relative peak intensity of 3HN increased smoothly with the 3HN 
concentration increased and overall peak intensity was much lower than 4HN and 5HN. 
Relative peak intensity of 4HN and 5HN increased rapidly before saturation, and the 
increasing rate of 5HN was greater than 4HN. Below the saturation, comparing peak 
intensity at the same concentration, 5HN had the highest peak intensity, while 3HN had 
the lowest peak intensity. In addition, 5HN reached saturation peak intensity at relative 
low concentration (0.05 mM), while 3HN and 4HN reached saturation peak intensity at 
higher concentrations (0.5 mM and 1 mM, respectively). After becoming saturation, 4HN 
and 5HN produced similar relative peak intensities that were much higher than that of 
3HN. The intensity variance was also larger after the saturation points as demonstrated by 
the error bars, which was in a good agreement with the PCA results. We didn’t test 5HN 
for higher concentrations because its solubility is very low and unable to be dissolved at 
higher concentrations. The concentration and relatively peak intensity at the saturation 
point of three PMFs were summarized in the Figure 4.12. 
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Figure 4.5 The raw SERS spectra of 3HN in different concentrations (0.05 – 3 mM). 
 
Figure 4.6 The raw SERS spectra of 5HN in different concentrations (0.005 – 1 mM). 
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Figure 4.7 The SERS spectra of 3HN in different concentrations (0.05 – 3 mM) after 2nd 
derivatives transformation. 
 
Figure 4.8 The SERS spectra of 5HN in different concentrations (0.005 – 1 mM) after 2nd 
derivatives transformation. 
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Figure 4.9 The PCA of 3HN SERS spectra in different concentrations (0.05 – 3 mM). 
PC1 and PC2 revealed 67.24%of total variance. 
 
Figure 4.10 The PCA of 5HN SERS spectra in different concentrations (0.005 – 1 mM). 
PC1 and PC2 revealed 96.25% of total variance. 
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Figure 4.11 The relationship of PMF concentration and relative peak intensity (indicative 
peak intensity over NO3- peak intensity). The indicative peak represented ring A, B, C 
deformation – assigned 3HN, 4HN, 5HN at 579 cm-1, 580 cm-1, 587 cm-1, respectively. 
 
Figure 4.12 The saturation concentration with its relative peak intensity, and binding 
percentage of three PMFs. 
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4.3.2 Determination of the binding affinity of three PMFs on Ag by HPLC 
In order to characterize the different SERS behaviors of three different PMFs, we 
determined the binding affinity of PMFs to Ag dendrites before saturation using HPLC. 
HPLC analysis was conducted to directly compare the PMFs concentration difference in 
the supernatant before and after incubating with Ag dendrites. By knowing the amount of 
PMF left in the supernatant, the amount of PMF molecules bound to Ag dendrite could be 
calculated. The percentage of bound PMFs was obtained from HPLC analysis (Figure 
4.12), and the results revealed that 36.13 ± 1.06% of 5HN, 18.40 ± 3.31% of 4HN and 
9.66 ± 0.94% of 3HN were bound to Ag dendrites. This result elucidated that higher peak 
intensity in the SERS spectra might be resulted by higher binding affinity of specific 
PMFs onto Ag dendrites.  
 
4.3.3 Possible conformations of three PMFs on Ag and their relationships to overall 
SERS enhancement 
Based on our previous studies, the number of hydroxyl group in the structure of PMFs is 
critical in their binding affinity with Ag dendrites.
46,152
 Although the three PMFs studied 
here are all monohydroxylated PMFs, their binding behaviors on Ag dendrites are very 
different, resulting in different SERS enhancement. These results demonstrated that in 
addition to the total number of hydroxyl groups, the position of the hydroxyl group is also 
critically important.  
 
Firstly, the overall spatial conformation of PMFs bound on Ag surface is determined by 
the position of the hydroxyl group. The possible binding site and spatial conformation of 
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PMFs on Ag dendrites surface was illustrated in the Figure 4.13. All 3 PMFs were 
attached to the Ag surface perpendicularly as demonstrated by the surface selection rule. 
5HN molecule tended to bind onto the Ag surface through the strong chelation of the 
hydroxyl group in the A ring and the carbonyl group in the C ring, and therefore one 
single molecule occupied relatively large surface area.
153,155
 Most interestingly, although 
both 3HN and 4HN had the hydroxyl group in the B ring, they behaved differently when 
attached on the Ag surface. 4HN has a hydroxyl group at 4 position, so it tended to bind 
onto the Ag surface with A and C rings straight up. 3HN has a hydroxyl group at 3 
position, so the A and C rings were more towards to the side. The whole 3HN molecule 
not only could be turned around by the central axis of C-O bond, but also the subpart of 
A ring and C ring could be turned round by the C-C bond between the B ring and C ring 
at certain angle. Once one 3HN molecule bound to Ag surface, the large potential space it 
occupied might prevent another 3HN binding to nearby binding sites. The uncertainty 
and flexibility of molecular conformation resulted in less and disorder attachment. The 
large variance within 3HN sample revealed by PCA (Figure 4.14) also supported the 
disordered attachment of 3HN on Ag. On the other hand, the 4HN molecule produced 
smaller space hindrance, even though the C-O bond and the C-C bond linked to the B 
ring and C ring could be turned around. The 5HN molecule was bound to Ag surface by 
both A and C rings, only the C-C bond linked to the B and C rings was turnable. The 
conformation of 4HN and 5HN illustrated those two molecules had more organized and 
uniform orientation when attached on the Ag surface. 
 
 90 
Secondly, our results showed that the position of the hydroxyl group also influenced the 
binding affinity of the PMFs on Ag. 5HN had the strongest binding affinity because the 
hydroxyl group which is in the A ring at position 5 could possibly chelate with carbonyl 
group in the C ring at position 4. 3HN had the lowest binding affinity. It may be due to 
the highly flexibility of 3HN orientation on the Ag surface and further experiment is 
needed for supporting this speculation. 
 
Lastly, our results revealed that the different spatial conformations and binding affinity of 
PMFs bound on Ag surface resulted in observed difference in the saturation point and 
SERS enhancement. Assuming the area of Ag surface for PMFs binding was the same, 
and one 5HN molecule occupied larger space, so less 5HN was needed to cover the 
surface completely compared to 4HN, resulting in a low saturation concentration of 5HN. 
It is noteworthy that the saturation peak intensity of 5HN was slightly greater than the 
saturation peak intensity of 4HN in the Figure 4.11. It is potentially due to the fact that 
the enhancement effect of SERS is distance-dependent,
161
 i.e. the maximum SERS 
enhancing region decreases extremely rapidly when the distance increases. The overall 
5HN molecule configuration was closer to the Ag surface than 4HN so that 5HN had 
higher saturation peak, but further investigation is needed to support this conclusion.  
Hence, before saturation, due to its stronger binding affinity and larger spatial 
conformation, 5HN had higher peak intensity than 4HN, and it became saturation at 
lower concentration. However, when the amount of PMF molecule was more than 
saturation, all binding sites on Ag surface were occupied by PMFs, both 4HN and 5HN 
showed similar saturation peak intensities. On the other hand, in the case of 3HN and 
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4HN, theoretically, they should have similar binding affinity to Ag surface in term of 
OH-Ag bond in the B ring. However, the spatial conformation of 3HN greatly limited its 
binding affinity. The potential binding sites were masked not only under large spatial 
occupation of one 3HN molecule, but also by highly disorder conformational attachment 
on Ag dendrites surface. Therefore, 3HN had the lowest peak intensity among the three 
PMFs tested. 
 
Figure 4.13 Illustration of possible binding sites and spatial conformation of PMFs on Ag 
dendrites surface. 
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CHAPTER 5 
MOLECULAR CHARACTERIZATION OF THE INTERACTIONS BETWEEN 
POLYMETHOXYFLANES AND KAPPA CASEIN 
 
5.1 Introduction 
Many potential health benefits and biological fate of flavonoids have been associated 
with their ability to interact and bind non-covalently to macronutrients in foods. 
Flavonoid–protein interactions are known phenomenon; those interactions not only play 
critical roles in food and beverage quality, including their taste, texture and other 
sensorial properties, but also the bioavailability and stability of flavonoids.
28–35
 To probe 
the interactions between flavonoids and proteins, it is very important to characterize the 
flavonoids–protein interactions at a molecular level and determine the molecular changes 
involved in the both molecules.  
 
There are growing interests on using an innovative analytical method, surface enhanced 
Raman spectroscopy (SERS), to characterize molecular interactions between ligands and 
proteins. SERS is a combination of Raman spectroscopy and nanotechnology. SERS 
provides the vibrational fingerprints of biomolecules by placing the analyte molecule 
onto a nanoscale metallic surface. The abilities to enhance Raman signal and reduce 
fluorescence background make SERS an emerging method for studying 
biomolecules.
39,112,121
 SERS has been used to study ligand–protein interactions by dye-
labeling methods and label-free methods. The dye-labeling methods need specially 
designed Raman reporter labeled silver or gold nanoparticle probes.
39–41
 The detection of 
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Raman reporter signals indicates the interaction between ligand and protein. The label-
free methods are based on the intrinsic signals of ligand and protein. The changes in the 
Raman spectra of ligand protein incubation, either spectral pattern or intensity, is a direct 
indication of ligand-protein interaction. It not only provides an insight into the mode of 
binding of the ligand to the protein, but also the protein conformation change.
42–46
 
 
Fluorescence quenching is a sensitive, simple, and rapid method to investigate the 
interaction and binding of flavonoids to proteins.
28,162–165
 A quencher molecule can 
decrease the quantum yield of fluorescence from a fluorophore induced by a variety of 
molecular interactions between the fluorophore and the quencher molecule. Dynamic or 
static quenching may be involved in the fluorescence process. Dynamic quenching results 
from collisional encounters between the fluorophore and quencher, whereas static 
quenching is due to the nonfluorescent complex of a quencher with a fluorophore. 
Fluorescence quenching not only reveals the accessibility of fluorophores to quencher, 
but also the localization of fluorophores in protein and their permeability to quenchers.
166
 
 
In this study, we aimed to characterize the molecular interactions between 
polymethoxyflavones (PMFs) and κ-casein using SERS and fluorescence spectroscopy. 
PMFs, a unique class of flavonoids, are abundant in the citrus peel, and have been 
received particular interest due to a broad spectrum of beneficial bioactivities including 
anti-inflammatory, anti-carcinogenic activities and anti-atherosclerosis.
3,5,22,50,52,150
 Two 
PMFs molecules, nobiletin (NBT) and 5, 3’, 4’- trihydroxylnobiletin (THN) were chosen 
in this study to investigate the importance of hydroxyl groups in the molecular 
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interactions with κ-casein. Casein is the major protein found in milk, constituting about 
80% of the total protein in milk, and four types of casein (αs1, αs2, β, κ) form casein 
micelle. Κ-casein is the outer layer of casein micelle and stabilize the micelle structure.167 
Therefore, κ-casein is considered as the major casein molecules involved in the 
interactions with flavonoids. Both native and thermal denatured κ-casein were tested to 
investigate the influence of protein structure and thermal processing on the protein-
flavonoid interactions. The results obtained through this study not only can help us to 
gain the fundamental understanding of the molecular mechanism of protein-flavonoid 
interactions, but also provide useful information to design a more stable and healthier 
functional food.  
 
5.2 Materials and methods 
5.2.1 Materials 
Κ-casein with purity of 70% was purchased from Sigma–Aldrich Chemical Co. (St. 
Louis, MO). The chemical structure of two PMFs, nobiletin (NBT), 5, 3’, 4’- 
trihydroxylnobiletin (THN) are shown in the Figure 3.1. NBT was purchased from 
Quality Phytochemicals LLC(Edison, NJ), and THN was synthesized from NBT as 
previously described.
5,21
 Reagents were obtained from Fisher Scientific (Waltham, MA), 
unless otherwise indicated. 
 
5.2.2 Preparation of stock solutions 
The native κ-casein solution (0.1%) was prepared fresh at the day of use. The thermal 
denatured casein solution was prepared by heating the κ-casein solution in water bath at 
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95 °C for 30 minutes, then cooling to room temperature. The PMFs stock solutions were 
20 mM in DMSO. 
 
5.2.3 Surface enhanced Raman spectroscopy (SERS) 
Silver (Ag) dendrites, a SERS substrate, were synthesized through a simple displacement 
reaction involving both zinc and silver nitrate in accordance to a previously published 
method.
119
 250 µL κ-casein solutions were incubated with 5 µL Ag dendrites for 30 
minutes under consistent orbital rotation at room temperature. The casein conjugated Ag 
was washed by double-distilled water 3 times to remove unspecific and oversaturated 
binding. The PMFs stock solutions were diluted by methanol to 1 mM. 5 µL casein 
conjugated Ag dendrites were added to 250 µL PMFs solutions, and incubated with for 
30 minutes under consistent orbital rotation at room temperature. The mixture was 
washed by double-distilled water 3 times, and then it was deposited onto a glass slide and 
air dried for Raman measurement. 
 
The detail of Raman spectroscopy and TQ analyst software were described in the section 
4.2.2. The parameters of the Raman measurement was also followed in the section 4.2.2. 
 
5.2.4 Fluorescence spectroscopy 
A SpectraMax m2e microplate reader (Molecular Devices, Sunnyvale, CA) was 
employed to quantify the binding of PMFs with κ-casein. A stock solution of 20 mM 
PMFs in DMSO was diluted to 0.05-0.5 mM in 50% methanol (v/v). For each data point, 
50 µL of the appropriate PMFs solution was added into 450 µL casein solution, to give a 
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final PMFs concentration in the range 0.005 - 0.050 mM. All measurements were made at 
room temperature and were conducted in triplicate. Control was casein solutions prepared 
with 2.5% DMSO in 50% methanol (v/v), without PMFs. The changes in the intrinsic 
fluorescence of native and thermal denatured κ-casein at varying concentrations of PMFs 
were measured and fluorescence excitation wavelength was set at 280 nm, and emission 
spectra were recorded from 300 to 450 nm. Fluorescence quenching was described using 
the Stern–Volmer equation,166 
F0/F = 1+KSV[Q]                                                                                                               [1]
 
where F0is the fluorescence intensity of casein control without PMFs, and F is the 
fluorescence intensity after addition of PMFs, [Q] is the concentration of PMFs, and Ksv 
is the Stern–Volmer quenching constant. Hence, the above equation is applied to 
determine the KSV using linear regression of a plot of F0/F against [Q]. A linear Stern-
Volmer plot generally means that only one mechanism, dynamic or static, when 
quenching occurs. 
 
When the relationship between F0/F and the concentration of quencher is no longer linear, 
but exhibits an upward curvature, concave toward the y axis at high [Q], it is described 
with a modified form of the Stern–Volmer equation,168 
F0/F = e
 (Kapp[Q])                                                                                                                                                                        
[2]
 
where Kapp is the apparent static quenching constant, and it suggests that the fluorophores 
and quenchers do not actually form a ground-state complex. Instead, the quencher is 
adjacent to the fluorophore at the moment of excitation, and these closely spaced 
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fluorophore-quencher pairs are immediately quenched, thus appears to be dark 
complexes. 
 
5.3 Results and discussion 
5.3.1 Surface enhanced Raman scatting characterization 
The raw Raman spectra of native and thermal denatured κ-casein were showed in the 
Figure 5.1. The 2
nd
 derivative Raman spectra of native and thermal denatured κ-casein 
were showed in the Figure 5.2. The band at 1662 and 1689 cm
-1
 in the native casein 
spectrum shifted to 1665and 1676 cm
-1
 in the thermal denatured casein spectrum, and 
those bands were related to amide I region. The band at 1249 cm
-1 
and 1275 cm
-1
 in the 
native casein spectrum shifted to 1242 cm
-1
 and 1270 cm
-1
, which corresponded to amide 
III bond.
108,169
 Those band shifts in amide I and III indicate the secondary structure 
change of casein after thermal treatment. Increased band intensity of band 642 cm
-1
, 824 
cm
-1
, 1169 cm
-1
, 1203 cm
-1
, and 1599 cm
-1
 which assigned as tyrosine (Tyr) were 
observed in the thermal denatured casein spectrum.
169 Κ-casein contains 9 Tyr residues, 7 
of Tyr residues are located between position 35 to 68 which represents an exceptionally 
hydrophobic area.
170
 The higher band intensity of Tyr residues might be caused by more 
hydrophobic area exposed in the thermal denatured casein than the native casein. 
Therefore, the thermal treatment resulted in conformational change of casein secondary 
and tertiary structure. Additionally, phenylalanine band (1002 cm
-1
) was not sensitive to 
conformational changes of protein, so it was used for normalization of the Raman spectra 
of protein for direct comparison.
108
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Figure 5.1 Raw Raman spectra of native casein and thermal denatured casein. 
 
Figure 5.2 Raman spectra of native casein and thermal denatured casein after 2nd 
derivatives transformation with peak assignment. 
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Different states of casein exhibited different binding affinity to the same PMFs. Raw 
Raman spectra of casein, casein incubated with NBT, and NBT were shown in the Figure 
5.3. Figure 5.4 presented the 2nd derivative Raman spectra of casein, casein incubated 
with NBT, and NBT. In the Raman spectrum of the native casein incubated with NBT, 
clear phenylalanine band at 1002 cm-1 from casein was shown, but no or very little 
signature band from NBT was observed. Previous study in our group also confirmed it by 
principal component analysis, and pointed out that there was no or very weak binding 
between NBT and native casein.46 Interestingly, after incubating the thermal denatured 
casein with NBT, the Raman spectrum exhibited increased NBT bands intensity (578 cm-
1, 1598 cm-1, 1626 cm-1). The signature band 578 cm-1 comes from A, B, C ring 
deformation, band 1598 cm-1 and band 1626 cm-1 are related to B ring quinoid stretch and 
C=O stretch, respectively.153,157,158 The higher band intensity resulted from stronger 
binding affinity of two molecules. Hence, the binding affinity of NBT to thermal 
denatured casein was much stronger than native casein. 
 
On the other hand, THN behaved an opposite manner when it interacted with casein. Raw 
Raman spectra of casein, casein incubated with THN, and THN were shown in the 
Figure 5.5. Figure 5.6 presented the 2
nd
 derivative Raman spectra of casein, casein 
incubated with THN, and THN. No matter which states of casein, the casein – THN 
spectra contained both signature bands of casein (1002 cm
-1
) and THN (582 cm
-1
, 1571 
cm
-1
) suggesting THN could interact with native casein and thermal denatured casein. 
The band 582 cm
-1 
and
 
band 1571 cm
-1 
are assigned as A, B, C ring deformation, and 5 
OH bend and C=O stretch, respectively.
153,158
 Interestingly, the band intensity of THN 
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(582 cm
-1
, 1571 cm
-1
) was much higher in the native casein – THN spectrum compared to 
thermal denatured casein – THN spectrum. Therefore, the binding affinity of THN to 
thermal denatured casein was lower compared to native casein.  
 
Moreover, Raman band shifts were further observed when THN interacted with casein 
(Figure 5.7). The band at 1324 cm
-1 is assigned as 5, 3’ OH bend, the band at 1571 cm-1 
is assigned as 5 OH bend and C=O stretch, and the band at 1620 cm
-1 is assigned as 5, 3’ 
OH bend in the THN spectrum were shifted to 1337 cm
-1
, 1566 cm
-1
, and 1612 cm
-1
 in 
the casein – THN spectra, respectively.153,157,158 The phenolic hydroxyl group is an 
excellent hydrogen bond donor and forms strong hydrogen bonds with the amide 
carbonyl of the peptide backbone or alkaline protein groups.
171
 Therefore, the hydrogen 
bond was formed between native casein and THN, which has three hydroxyl groups. The 
decreased band intensity of those bands in thermal denatured casein-THN spectrum 
means lower hydrogen bonding between the thermal denatured casein and THN. 
 
Different PMFs also exhibited different binding affinity to the same state of casein. In the 
Figure 5.4, the ratio of fingerprint band intensity of NBT assigned as A, B, C ring 
deformation (578 cm
-1
) over casein phenylalanine (1002 cm
-1
) band intensity was lower 
than 1. While, the ratio of fingerprint band intensity of THN assigned as A, B, C ring 
deformation (582 cm
-1
) over casein phenylalanine (1002 cm
-1
) band intensity was greatly 
higher than 1 when the THN concentration was 0.1 mM (Figure 5.6). When same 
amount of PMFs were added to same amount of casein, THN showed higher band 
intensity indicating that more THN were bound to casein. Hence, THN revealed stronger 
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binding affinity to casein than NBT. The different structure of flavonoids largely affect 
their binding affinity with protein. Particularly, methoxylation of flavonoids decreased 
the binding affinity, while hydroxylation on the A and B ring of flavones increased the 
interaction.
29
 THN has one hydroxyl group at the position 5 on the A ring and two 
hydroxyl groups at the position 3’ and 4’ on the B ring significantly enhances its binding 
to casein. 
  
Figure 5.3 Raw Raman spectra of casein, native casein incubated with NBT, thermal 
denatured casein incubated with NBT, and NBT. Compared to NBT spectrum, other 3 
spectra enlarged 4 times. 
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 Figure 5.4 Raman spectra of casein, native casein incubated with NBT, thermal 
denatured casein incubated with NBT, and NBT after 2nd derivatives transformation. 
Compared to NBT spectrum, other 3 spectra enlarged 6 times. 
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Figure 5.5 Raw Raman spectra of casein, native casein incubated with THN, thermal 
denatured casein incubated with THN, and THN. Compared to THN spectrum, casein 
spectra enlarged 10 times, native casein-THN spectrum and thermal denatured casein-
THN spectrum enlarged 3 times. 
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Figure 5.6 Raman spectra of casein, native casein incubated with THN, thermal denatured 
casein incubated with THN, and THN after 2nd derivatives transformation. Compared to 
THN spectrum, other 3 spectra enlarged 2 times. 
 
 
Figure 5.7 Raman band shifts of native and thermal denatured casein interacted with 
THN after 2nd derivatives transformation. 
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5.3.2 Fluorescence quenching spectroscopy 
Figure 5.8 showed the typical fluorescence emission spectra obtained for native casein 
with the addition of NBT and THN, at 280 nm excitation. The casein exhibited a strong 
fluorescence emission with a peak at 335 nm. The fluorescence intensity of casein 
emission peaks inversely decreased with the increasing concentration of NBT and THN. 
The decline in the fluorescence intensity was caused by quenching, but there was no 
significant emission wavelength shifts with the addition of NBT and THN. The same 
trend was observed by NBT and THN with thermal denatured casein shown in the Figure 
5.9. Since κ-casein contains one Trp residue at position 76,170 no significant emission 
wavelength shifts suggested that there was no change in the immediate environment of 
the tryptophan residues, other than the fact that the PMFs were situated at close proximity 
to the tryptophan residue for the quenching to occur. It could be further interpreted that 
the molecular conformation of casein was not significantly affected by PMF interactions.  
 
The Stern-Volmer plots of F0/F versus concentration of PMFs did not exhibit good linear 
relationship, but an upward curvature, concave towards the y-axis. (Figure 5.10.) It was 
indicative of both dynamic and static quenching involving in the interaction. In this case, 
the modified Stern-Volmer equation described by Eq. [2] was applied. The concentration 
dependence of the fluorescence intensity of casein was analyzed using modified Stern-
Volmer plot of ln(F0/F) as a function of concentration of PMFs shown in the Figure 5.11. 
The Stern-Volmer constant can be described by an apparent static quenching constant 
(Kapp), with a nonspecific binding, as both dynamic and static quenching occur. The 
particular quenching behavior further confirmed that PMFs and casein did not actually 
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form a ground-state complex, but PMFs was adjacent to the casein at the moment of 
excitation. PMFs were situated at close proximity to casein but did not enter into the 
casein molecule. 
 
Table 5.1 summarized the calculated Kapp for PMFs and κ-casein. The apparent 
quenching constants were statistically different between NBT and THN to different states 
of casein. The NBT showed higher quenching constant to the thermal denatured casein 
than the native casein. However, the quenching constant of THN to the thermal denatured 
casein was lower than it to the native casein. In addition, for native casein, the quenching 
constant of THN was higher than NBT. While, for thermal denatured casein, it did not 
show significant difference between NBT and THN. 
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Figure 5.8 Emission spectra of 0.05% native casein at λex = 280 nm showing the 
quenching effect of increasing concentrations of (A) NBT (0, 5, 10, 15, 20, 25, 30, 40, 50 
µM) and (B) THN (0, 5, 10, 15, 20, 25, 30, 40, 50 µM). 
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Figure 5.9 Emission spectra of 0.05% thermal denatured casein at λex = 280 nm showing 
the quenching effect of increasing concentrations of (A) NBT (0, 5, 10, 15, 20, 25, 30, 40, 
50 µM) and (B) THN (0, 5, 10, 15, 20, 25, 30, 40, 50 µM). 
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Figure 5.10 Stern–Volmer plot. (plot of F0/F against the corresponding concentrations of 
(A) NBT for native casein and thermal denatured casein; (B) THN for native casein and 
thermal denatured casein.) 
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Figure 5.11 Modified Stern–Volmer plot (plot of ln (F0/F) against the corresponding 
concentrations of (A) NBT for native casein (y=0.0246x, R2=0.994) and thermal 
denatured casein (y=0.0272x, R2=0.0994); (B) THN for native casein (y= 0.0378x, 
R2=0.992) and thermal denatured casein (y=0.029x, R2=0.991)). 
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Kapp (µM
-1
) NBT THN 
Native casein 0.0246±0.0007 
aA
 0.0378±0.0016 
aB
 
Thermal denatured casein 0.0272±0.0012 
bA
 0.0290±0.0010 
bA
 
 
Table 5.1 Modified Stern–Volmer quenching constants, Kapp (μM-1) for the interaction 
of PMFs with native and thermal denatured casein. Results are the average of three 
independent experiments. Within a column, values with different superscript same letters 
are significantly different (p < 0.05). Within a row, values with different superscript 
capital letters are significantly different (p < 0.05). 
 
5.3.3 Proposed mechanism of PMFs-casein interactions 
The mechanism of flavonoids-protein interaction has been reported that complex 
formation results from hydrogen bonding, hydrophobic interaction and ionic interaction 
for non-covalent bonding.
28,165,171–174
 Hydrogen bonding involves H-acceptor sites of the 
proteins, such as peptide backbone or alkaline protein groups and the hydroxyl groups of 
the polyphenols. Hydrophobic interactions results from aromatics rings of polyphenols 
and hydrophobic sites of proteins, such as pyrrolidine rings of prolyl residues. Ionic 
bonds occurs between positively charged groups of proteins, such as ε-amino groups of 
lysine, and negatively charged hydroxyl groups of polyphenols. Casein has negative 
charge in the neutral pH, while PMFs have net charge in the neutral pH. Therefore, the 
ionic bond could be ruled out in this specific interaction.  
 
Both SERS study and fluorescence study have consistent results that the binding affinity 
of NBT to the native casein was lower than it to the thermal denatured casein, while the 
binding affinity of THN to the native casein was higher than it to the thermal denatured 
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casein. NBT with no hydroxyl group interacted with casein mainly through hydrophobic 
interaction. After casein was thermal denatured, it exposed more hydrophobic area as 
shown in the Raman spectra, therefore, the increased binding affinity was due to the 
increased hydrophobic interaction. THN with three hydroxyl group interacted with casein 
through hydrophobic interaction and hydrogen bonding, and hydrogen bonding was the 
driving force. Increasing temperature can destroy the hydrogen binding site and decrease 
hydrogen bonding.
175
 Therefore, the binding affinity of THN to the thermal denatured 
casein decreased. Sastry and Prigent also reported that 5-O-caffeoylquinic acid bound 
less to the polyphenol-free 11S protein of sunflower seed and bovine serum albumin with 
increasing temperature, suggesting hydrogen bonding dominated the interaction
176,177 
Additionally, THN has a stronger binding affinity than NBT to casein, both the native 
and the thermal denatured states. This also demonstrated the increased binding affinity of 
THN compared to NBT with casein was due to the hydrogen bonding. 
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CHAPTER 6 
CONCLUDING REMARKS 
 
Polymethoxyflavones (PMFs) have received a considerable interest due to their 
remarkable bioactivities. In my dissertation, the current two significant gaps in our 
understanding of the bioactivity of PMFs were investigated. A study of the 
biotransformation of polymethoxyflavones (PMFs) by the mouse and human microbiome 
showed that glucuronide and/or sulfate conjugates of NBT, 5HN and their metabolites 
were largely deconjugated by both mouse and human gut microbiome. Deconjugation of 
these conjugates enabled reuptake of free active PMFs by enterohepatic circulation. The 
human gut microbiome also catalyzed the demethylation at certain positions of flavonoid 
core structures, e.g. 3' and 4' positions in the B ring, and position 4’ was more preferred 
than position 3’. Inter-individual variations were observed in different human subjects in 
terms of demethylation. Moreover, our results using cell culture models demonstrated 
that isolates generated after gut microbiome fermentation showed much stronger anti-
carcinogenic effects than isolates without gut microbiome fermentation. Thus, the gut 
microbiome is a key player in biotransformation of PMFs. We provided the first report of 
the biotransformation of PMFs by the mouse and human gut microbiome with its 
potential for enhancing health benefits of PMFs. In the second part of the dissertation, we 
applied a novel analytical method to characterize monohydroxylated PMFs and their 
SERS behavior. According to SERS spectra, PCA and HPLC analysis, the position of 
hydroxylation is a crucial factor for molecular interaction between PMFs and Ag 
dendrites, the spatial conformation of PMFs on binding sites, the binding affinity, and the 
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saturation concentration. 5HN exhibited the highest binding affinity and the lowest 
saturation concentration mainly because of the stronger interaction to Ag through 
chelation. 3HN produced the lowest binding affinity, primarily due to a highly disorder of 
molecular conformation. This study, for the first time, reported that the position of 
hydroxylation in monohydroxylated PMFs was crucial for their interaction with Ag 
dendrites and advanced the fundamental understanding of the relationship between 
molecular structure and the interaction with Ag substrate. We further characterized the 
molecular interaction between PMFs and kappa casein. Both SERS and fluorescence 
spectroscopic studies revealed the structure of PMFs (i.e. with or without hydroxyl 
groups) and casein state (i.e. native or thermal denatured) affect their binding affinity. 
This study demonstrates the significance of flavonoids structure and protein states on the 
flavonoid- protein interactions. It also shows the feasibility of SERS as a powerful tool to 
characterize the molecular flavonoid-protein interactions. Overall, this dissertation 
provides important leads for further investigation on the bioactivities of PMFs. 
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